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ABSTRACT
Autism Spectrum Disorder (ASD) is a lifelong neurodevelopmental disorder with
hallmark symptoms that can be severely impairing to both the individual and the overall family
dynamic. The path to diagnostic and therapy services is often lengthy and complex. Despite
various state and federal efforts to improve service access, disparities remain evident across
ethnic, socioeconomic, and geographic lines with caregivers reporting financial, cultural,
geographic, and practical (e.g., transportation, scheduling) barriers. For those able to access
treatment, several interventions have been proven efficacious in addressing ASD symptoms,
problem behaviors, and adaptive skills deficits. Other often-used interventions include those
without established merit for ASD. This study found a tendency for income, insurance type, and
ethnicity to affect service access. Out of pocket costs remain a significant barrier to evidencebased services. Scheduling difficulties and long wait lists impact diagnostic services, as do
perceptions of misguided reassurances from professionals (e.g., healthcare worker stating “he’ll
grow out of it”). Disparities in service use indicate a need to develop policy, practice, and
family-level strategies to address barriers to ASD services.
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CHAPTER 1: INTRODUCTION
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder marked by
difficulties in three domains: communication, socialization, and restricted or repetitive behaviors,
activities, or interests (e.g., hand flapping, preoccupation with parts of objects, intense interest in
narrow subjects; Matson, Dempsey, & Fodstad, 2009). As a neurodevelopmental disorder, ASD
is present from birth, is typically evident in early childhood, and is usually diagnosed in the first
few years of life. Until the recent publication of the 5th edition of the Diagnostic and Statistical
Manual of Mental Disorders in May 2013 (DSM-5; American Psychiatric Association [APA],
2013), ASD as a DSM-IV-TR category included five disorders. As outlined in the previous
version of this widely used manual, the DSM-IV-TR (APA, 2000), these disorders included
Autistic Disorder, Asperger’s Disorder, Rett’s Disorder, Childhood Disintegrative Disorder, and
Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS); each disorder was
marked by varying degrees of deficiencies in communication, social skills, and repetitive /
restricted behaviors or interests.
Significant changes in ASD diagnostic criteria in the DSM-5 (APA, 2013) include
removal of Rett's Disorder and the collapse of the remaining diagnoses into one diagnosis:
Autism Spectrum Disorder. Socialization and communication deficits have been combined into
one domain in which an individual must meet all three symptoms (i.e., deficits in nonverbal
communication during social interactions, lack of social reciprocity, and deficits in developing
and maintaining developmentally appropriate relationships) in order to receive an ASD diagnosis
(APA, 2013). Under the DSM-5, individuals must also meet two of the following criteria:
stereotyped or repetitive speech, motor movements, or object use; adherence to routines or
ritualized patterns of behavior; highly restricted interests which are abnormal in intensity or
1

focus; or abnormal hypo- or hyper-reactivity to sensory input. The age of onset criterion
includes early childhood, noting that some symptoms may not be fully evident until social
demands exceed the individual’s level of functioning. To fully meet criteria for an ASD
diagnosis, symptoms must negatively impact the individual’s ability to function in activities of
daily living. Lastly, individuals carrying an ASD diagnosis that was diagnosed using the DSMIV-TR are permitted to retain their ASD diagnosis as the DSM-5 is adopted. In the future,
however, these changes will undoubtedly impact the prevalence of ASD.
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CHAPTER 2: PREVALENCE AND DIAGNOSTIC DISPARITIES
Prevalence of Autism Spectrum Disorder
In the early years of diagnostic conceptualization, ASD was considered to be a very rare
disorder. Mid-20th century prevalence estimates indicated fewer than 10 in 10,000 individuals
met ASD criteria at that time (Sevin, Knight, & Braud, 2007). Prevalence rates have increased
drastically from these early estimates, reaching approximately 30-60 per 10,000 in the early
1990s (Inglese & Elder, 2009). Prevalence estimates released by the Centers for Disease Control
and Prevention (CDC) indicated a prevalence of 1 in 150 in 2007 (CDC, 2007). More recent
estimates increased to 1 in 88 (CDC, 2012) and then 1 in 68 (CDC, 2014), with a corresponding
rise in concern about an autism “epidemic.” Throughout the years, the male to female ratio
described by Leo Kanner in the 1940s of approximately 4:1 has remained stable (Bertoglio &
Hendren, 2009; Dawson, Mottron, & Gernsbacher, 2008; Rice et al., 2010; Inglese & Elder,
2009). In a recent epidemiological study, researchers estimated that there is little regional
variation worldwide in ASD prevalence, with an average rate of approximately 1 in 132 (Baxter
et al., 2014).
While ASD diagnostic rates have undoubtedly increased over the years, it is impossible
to pinpoint a specific reason for the increase. It is likely that a confluence of factors have
contributed to increased diagnostic rates. Differing methodology in various estimates affects
results (Fombonne, 2009, Matson & Kozlowski, 2011). Furthermore, prevalence rates have been
affected by changes to the criteria between DSM editions (Fombonne, Quirke, & Hagan, 2009;
Matson & Kozlowski, 2011; Shattuck, 2006). Changes to criteria over the years may lead to
diagnostic substitution; even minor changes in criteria may shift individuals from meeting
criteria in one diagnostic category to another, and thus effect change in apparent prevalence rates
3

(Fombonne, 2009; Matson & Shoemaker, 2009). For example, changes between DSM editions
have led to concomitant increases in ASD rates and decreases in intellectual disability (ID) rates
in a process called diagnostic substitution (Fombonne, 2009; Leonard et al., 2010), though now it
is customary to give both diagnoses where warranted with ASD as a primary diagnosis and ID as
a secondary diagnosis (Matson & Shoemaker, 2009). ASD criteria were most recently updated
with the release of the DSM-5 in 2014; it is as yet unclear how much this change will affect
prevalence rates. Though only time will tell, some researchers anticipate 30% or more decrease
in new diagnoses due to the introduction of more stringent criteria that would likely exclude
many who met DSM-IV-TR criteria for PDD-NOS, Asperger’s Disorder, or ASD without
concurrent ID (Frazier et al., 2012; Matson, Belva, et al., 2012; Mattila et al., 2011; McPartland
et al., 2012; Worley & Matson, 2012).
Other factors impacting prevalence rate include increased awareness and acceptance of
ASD, increased awareness of early symptoms, and increased service availability and screening
efforts (Fombonne, 2009; Koenig et al., 2000; Leonard et al., 2010; Matson & Kozlowski, 2011).
Increased awareness of ASD can lead to better identification, treatment, and outcome for many
affected individuals, but increased awareness also increases the chance for misdiagnosis. ASD
diagnosis can be complicated by heterogeneity of symptom expression and symptom overlap
with other conditions (e.g., communication disorders; Matson & Kozlowski, 2011); it is likely
that inexperienced clinicians may occasionally misdiagnose ASD, and it is possible that ASD
diagnosis is being over-used (Leonard et al., 2010; Matson & Kozlowski, 2011). Additionally, it
is possible that shifting environmental factors contribute to increased actual cases of ASD.
Etiology is yet undetermined, but research indicates a confluence of biological and
environmental factors increase the risk for ASD symptoms (Inglese & Elder, 2009). Fortunately,
4

the survival rate for premature births has increased significantly over the years; however,
prematurity is recognized as a risk factor for later ASD diagnosis (Matson & Kozlowski, 2011).
Improved medical care likely contributes to increased survival of children with risk factors (e.g.,
prematurity, genetic conditions) who go on to receive an ASD diagnosis.
Other factors affecting prevalence estimates include geography and cultural factors.
Particularly in Asian countries, the concept of ASD is a relatively new one (Leonard et al., 2010;
Matson & Kozlowski, 2011). In the United States, recent estimates have found significant
differences in prevalence across ethnic groups; for example, the 2007 estimates released by the
CDC noted significantly higher rates of ASD in non-Latino white children compared to minority
groups (CDC, 2007). Perhaps affected by increased awareness and culturally sensitive diagnostic
efforts, a decrease in the ethic gap was noted in the 2012 CDC report, though differences still
exist (CDC, 2012), as discussed in the section on Diagnostic Process.
Diagnosis and Diagnostic Disparities
ASD is a neurodevelopmental disorder, so it is unsurprising that symptoms often become
evident early on in life. Currently, researchers indicate that ASDs can often be reliably
diagnosed as early as 18 months of age, with some researchers positing that the appropriate
screening tools and assessment practices can reliably diagnose some children as young as 12
months of age (Council on Children with Disabilities, 2006; Kim & Lord, 2012). Parents often
report concerns about their child’s development before one year of age, long before other
caregivers or healthcare providers notice concerning signs (Kishore & Bashu, 2011). Jónsdóttir
and colleagues (2011) found that of children who later received an ASD diagnosis, 76.2% of
parents were concerned about their child’s development before 3 years of age (Jónsdóttir,
Saemundsen, Antonsdóttir, Sigurdardóttir, & Ólason, 2011).
5

Despite parents’ early concerns, many children are not diagnosed with ASD until school
age. Shattuck and colleagues (2009) reviewed educational and medical records from 13 sites
across the United States, and found that the median age at ASD diagnosis was 5.7 years. In this
same study, the researchers noted that 27% of the students had undiagnosed ASD at age 8 years.
Under the DSM-IV-TR criteria, which divided ASDs into Autistic Disorder, PDD-NOS, and
Asperger’s Syndrome, the CDC (2012) found the average age of diagnosis ranged from 4 years
(Autistic Disorder) to 6 years, 3 months (Asperger’s Disorder). In the case of children with
Autistic Disorder, the most severe ASD category in the DSM-IV-TR, Chakrabarti (2009) found
parents became concerned about their child’s development when the child was around 23.4
months of age, and sought professional help approximately 4 months later. Despite an average
point of first professional contact around 27 months, the mean time from the first evaluation to
the diagnosis was 32 months (Chakrabarti, 2009). In total, this indicates a gap of about 2.5 years
from point of first concern to a formal ASD diagnosis for the most severely affected category of
children in this study—time during which the child and family might have benefitted from early
intervention services. Interestingly, maternal age over 35 years has been associated with later
recognition of autism symptoms by parents (Chawarska et al., 2006).
Many children receive one or more other psychological and/or developmental diagnoses
before finally receiving an ASD diagnosis. To investigate the possibility of misdiagnosis,
Yeargin-Allsopp and colleagues (2003) conducted a thorough review of educational and/or
medical records to ascertain whether an ASD diagnosis was present in prior records and found
18% of children enrolled in special education services at that time had not been correctly
classified as having an ASD. It can take months to receive an accurate ASD diagnosis even when
developmental concerns are noted early on. Symptoms are heterogeneous, and may emerge or
6

change over time, highlighting the necessity of periodic re-evaluation. Individual factors
associated with later diagnosis include being female, IQ over 70, moderate to mild ASD
symptoms, and absence of developmental regression (Shattuck et al., 2009).
Recent efforts to improve early diagnosis have increased general awareness of early
symptoms among parents and health care professionals, and resulted in greater research and
development of measures designed for early ASD screening. These efforts have contributed to
decreases in the average age of diagnosis (Charman & Baird, 2002). However, evident disparities
in the diagnostic process still exist. Race, ethnicity, socioeconomic status (SES), and rural versus
urban location remain concerns for professionals seeking to improve diagnostic and treatment
services.
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CHAPTER 3: INTERVENTIONS
According to the American Psychological Association, evidence-based practice (EBP) is
practice that applies empirically supported principles to integrate the best available research with
clinical expertise in the provision of psychological interventions (APA, 2002). The APA
encourages EBP to “promote effective psychological practice and enhance public health,” while
acknowledging that an intervention that has not yet been carefully studied may one day prove to
be effective (APA, 2002). Establishing treatments as EBP requires multiple carefully conducted
research trials, and it takes time to gather enough strong evidence for any new efficacious
intervention to become widely recognized as EBP. The need for establishing guidelines to
separate EBP and non-EBP is based in the potential dangers of providers delivering non-EBP.
Some non-EBPs may eventually be proven efficacious after adequate research, but wide use of
non-EBPs exposes treatment-seeking individuals to greater risk of wasting time and resources on
ineffective interventions, instead of allocating resources towards those interventions more likely
to be efficacious. Greater ill effects of pursuing non-EBPs are also possible. In the treatment of
ASD, non-EBPs range from relatively benign (e.g., animal-assisted therapy) to downright
dangerous (e.g., chelation therapy), including controversial treatments (shock therapy) and
interventions that have been proven effective for other conditions but not for ASD (e.g., glutenfree diet for individuals with celiac disease; National Autism Center, 2015). Navigating the
ocean of touted autism interventions can be daunting with information regarding both EBP and
non-EBP readily available via social media, support groups, etc. Information on EBP and nonEBP can even be found in the grocery checkout aisle (at least in Austin, Texas), where in 2012
the author picked up issues of Autism Science Digest (issues 3 and 4) and Autism File: Hope and
Help for Autism Families (issue 44). These magazines had headlines such as “Fermentation and
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the Gut: The Suppression of Science,” “Stem Cell Therapy, Quantitative EEG, & Fecal
Microbiota Transplantation,” “Breakthrough Vision Therapy: Transforming Learning and
Behavior” and “Therapeutic Application of Transcranial Magnetic Stimulation in Autism
Spectrum Disorders.” When one can so easily pick up scientific-sounding journals with articles
written by MDs including statements such as “Hyperbaric therapy has been shown to be
beneficial in the treatment of autism. . . it is possibly that hyperbaric therapy may be acting
through mitochondrial hormesis to decrease oxidative stress and improve underlying metabolic
abnormalities in autism” (van Dyke, 2012) it is no wonder that parents may have difficulty
sorting out the wheat from the chaff when making treatment choices. (It appears that the Autism
Science Digest is now defunct, although its parent organization, Autism One, still hosts popular
annual conferences for parents with topics similar to those found in the former Digest.)
The National Autism Center initiated the National Standards Project to provide
guidelines informing professionals, educators, and caregivers about which treatments have been
shown effective in treating individuals with ASD (National Autism Center, 2015). The National
Standards Project categorizes a number of ASD interventions as established interventions,
emerging interventions (supported by some preliminary research results, but studies are not of
number and/or rigor to qualify them as EBP), and unsubstantiated.
Deyro and colleagues (2014) surveyed parents of children with ASD regarding available
ASD treatments and their perceived effectiveness and scientific validity of treatments included in
the National Standards Project. These researchers found that the majority of parents agreed with
the National Standards Report for only 9 out of the 26 treatments included in their survey. The
authors concluded much work remains for professionals who regularly interact with parents of
children with ASD in educating them and guiding them towards treatments most likely to be
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efficacious. Complicating this goal, some non-EBPs are frequently recommended by clinicians
and advertised on the internet in places likely to be frequented by parents (Deyro, Simon, &
Guay, 2014).
Established Interventions for Autism Spectrum Disorder
Methods Using Principles of Applied Behavior Analysis (ABA)
According to the National Standards Project, the principal category of established ASD
interventions is Behavioral Interventions. This category includes a number of behavioral
intervention packages that incorporate antecedent interventions (to modify the situational events
typically preceding a target behavior) and consequent interventions (making changes to the
environment following an instance of the target behavior; NAC, 2015). The identification of
antecedent and consequent interventions is generally based on Applied Behavior Analysis
(ABA), a process of systematically applying behavioral principles of human behavior and
learning to effect desirable change in social behaviors (e.g., decreasing problem behaviors,
teaching functional social skills and alternate behaviors, and increasing desirable behaviors in the
appropriate situational context). In the course of the National Standards Project, 298 research
articles on behavioral interventions were reviewed in the first phase and 155 articles in the
second phase, providing an ample research base supporting the efficacy of behavioral
interventions.
Complicating the description of these most effective behavioral treatments, many
intervention packages share ABA-based application techniques. Common elements include
prompting, shaping, use of natural consequences, naturalistic teaching strategies, contingent
reinforcement, differential reinforcement, extinction, chaining, function-based intervention,
reinforcement schedules, response interruption and redirection, joint attention intervention,
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stimulus fading, modeling (video and/or live), repeated practice, discrete trial training, and other
techniques. An in-depth description of these ABA-based elements is beyond the scope of this
paper, but the interested reader may consult Matson (2009) and Fisher and Piazza (2013) for
greater detail of these and other individual components. Early Intensive Behavioral Intervention
(EIBI) is a behaviorally-based intervention; however, as EIBI is often studied as a separate
treatment package, and is limited to the first years in life (early childhood), it will be discussed in
more depth below.
Early Intensive Behavioral Intervention (EIBI)
Early intensive behavioral intervention (EIBI) is a treatment based on the principles of
applied behavior analysis. EIBI is also sometimes referred to as Comprehensive Behavioral
Treatment for Young Children (CBTYC; NAC, 2015). This intervention is usually delivered for
2-3 years starting in early childhood at an intensity of 20 to 40 hours per week. Typical
interventions include discrete trial teaching, incidental teaching, behavioral momentum, shaping,
modeling, errorless learning, and other ABA-based techniques. Instruction may be carried out in
multiple settings such as home, community, inclusive classrooms, self-contained classrooms, and
small group instruction (NAC, 2015). Each program is highly individualized but nonetheless
includes a strong application of ABA-based strategies. The National Standards Project reports of
EIBI/CBTYC were based on the review of 21 and 20 studies respectively in phases 1 and 2 of
the project. EIBI is one of the most well-studied and research-supported interventions for
improving prognosis for young children diagnosed with ASD (for review, see Reichow, Barton,
Boyd, & Hume, 2012; and Tonge, Bull, Brereton, & Wilson, 2014).
Within the context of the family, early intervention services for children with ASD can
support positive outcomes not only for the individual, but also for the family unit. On an
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individual level, early intervention can improve social skills, communication skills, challenging
behaviors, family functioning, and perhaps even IQ (American Academy of Pediatrics
Committee on Children with Disabilities, 2001; Committee on Educational Interventions for
Children with Autism, 2001; Manning-Courtney et al., 2003; Martinez-Pedraza & Cater, 2009;
Matson, 2007; OCDD, 2012; Symes, Remington, & Brown, 2006), reducing the impact of delays
and potentially decreasing the intensity needed for future supports. Ben-Itzchak and Zachor
(2007) conducted a review of early behaviorally-based intervention studies, and found that
approximately half of participants later exhibited significant improvement in standardized testing
scores, peer to peer interactions, and functioning in mainstream classes. On a family level, early
intervention services may reduce the future costs to meet special education, rehabilitation and
health care needs; reduce feelings of isolation, stress, and frustration by family members and
caregivers; and help children become more productive and financially and socially independent
of primary caregivers in the future (Matson, 2007; OCDD, 2012).
Clinicians and researchers generally agree that an earlier diagnosis and subsequent
treatment based on the principles of applied behavior analysis improves overall prognosis
(Matson, Wilkins, & Gonzalez, 2008), in addition to improving family functioning.
Acknowledging the importance of early intervention services in promoting positive outcomes, in
1986 the United States Congress established Part C (Early Intervention) of the Individuals with
Disabilities Education ACD (IDEA). Legislators recognized the “urgent and substantial need” to
improve the development of infants and toddlers with disabilities, reduce educational costs by
diminishing the later need for special education, curtail the likelihood of institutionalization
while increasing independence, and support the ability of families to meet their child's needs
(Data Accountability Center, 2012). Recognition of the value of early intervention has increased
12

focus on early detection (Gutierrez et al., 2009; Hayward, Gale, & Eikeseth, 2009), and programs
to make early intervention services accessible irrespective of SES.
Cognitive Behavioral Intervention Package (CBIP)
Between publication of National Standards Project phase 1 and phase 2 results, the
cognitive behavioral intervention package was moved from the “emerging interventions”
category and recategorized as an established intervention (NAC, 2015). Cognitive behavioral
therapy (CBT) has been used as an evidence-based intervention for many years in the treatment
of anxiety and mood disorders in individuals without ASD. Per National Standards Project
review of 13 research studies investigating the use of CBT in individuals with ASD, manualized
CBT with a few modifications can be an effective intervention for individuals with ASD.
Modifications may include the addition of visual cues, use of role-play, and other elements of
individualized structure added to the session. Common CBIP strategies include psychoeducation
around identifying and describing emotions and corresponding physiological components.
Cognitive restructuring can be used in a manner very similar to the way in which it is used for
individuals without ASD to assist in recognizing and modifying cognitive distortions such as allor-nothing thinking or catastrophizing. Like other manualized CBT interventions for individuals
without ASD, use of CBT in the course of ASD includes use of a scale to identify the magnitude
of various distressing situations, homework assignments to record behavioral observations and
work on identified skills at home and school/community, and parent sessions or inclusion of
parents in parts of the intervention sessions (NAC, 2015). Manuals reviewed by the NAC (2015)
for use in individuals with ASD include the Coping Cat Program and the Exploring Feelings
program.
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Language Production Training
Language production training is often, but not always, given in the form of speech
therapy sessions. Language production training targets the use of functional, spoken (verbalized)
language communication. Intervention begins with assessment and identification of
developmentally appropriate targets, followed by use of a variety of strategies to elicit functional
verbalizations. Strategies include modeling, prompting (e.g., verbal, visual, or gesture), cuepause-point procedure, incorporation of music, and reinforcement for production of the targeted
verbal response (NAC, 2015).
Parent Training Package
In the first phase of the National Standards Project, elements of the parent training
package were reviewed individually; however, in the second phase, elements of parent training
which generally occur in tandem were investigated as a whole. Effective parent training can
occur in a variety of forms including in vivo, group training, support groups with an educational
component, and training manuals. Skills commonly taught to the parents include strategies to
cultivate imitation skills, commenting on the child’s behavior, expectant waiting to elicit
communication, increasing joint attention, developing play date activities, and fostering suitable
sleeping routines (NAC, 2105).
Peer Training Package
Many individuals with ASD desire and attempt to interact with peers, but do so in
counterproductive ways. Similar to the parent training, in peer training skills are taught to those
who regularly interact with the individual in order to help foster the individual’s social and other
adaptive skills. One goal of peer training is to decrease an individual’s reliance on adults for
prompting and guiding, and to instead train peers how to initiate and respond to social
14

interactions with an individual with ASD. These programs are used primarily in school and
community settings, and have been found effective in increasing communication and
interpersonal skills as well as decreasing restricted, repetitive behaviors, interests, or activities in
shared social settings. Important factors for consideration include the maturity and skill level of
the child with ASD as well his/her peers, activities that incorporate interests of all parties
involved to increase motivation, and teaching of specific skills for peers to get attention of the
individuals with ASD in order to model appropriate play skills, facilitate sharing, provide help,
and organize play activities (NAC, 2015). Interaction should occur in a structured setting around
familiar activities with the instructor available to provide prompts and feedback. Training should
occur in multiple settings and with a variety of peers. Some of the effective peer training
curriculums/strategies in the National Standards Project include Project LEAP, circle of friends,
buddy skills packages, facilitated integrated play groups, peer initiation training, and peermediated social interaction training.
Pivotal Response Training (PRT)
Like other EBPs discussed above, PRT makes use of ABA-based techniques. Unlike
some of the previously discussed treatments, PRT is a package carrying a registered trademark; it
was registered by Koegel and Koegel, researchers from Santa Barbara, California. PRT focuses
on naturalistic teaching strategies. Rather than focusing on specific target behaviors, PRT targets
motivation, responsiveness to cues, self-management, empathy, and self-initiated activities.
Child choice, natural and direct reinforcers, and interspersing maintenance tasks, and variation of
tasks are used to maintain motivation. Of note, these strategies are not unique to PRT and are
often incorporated in other ABA-based approaches as well. Delivery of PRT relies on parent
involvement and implementation in the natural environment such as home, community, and
15

school setting. National Standards Project’s review of PRT yielded a total of 16 research studies
focusing on PRT; reviewers concluded these studies were of sufficient rigor to qualify the PRT
package as an established intervention for ASD (NAC, 2015).
Schedules
Individuals with ASD often respond better to visual than to auditory cues, and many have
difficulty with transitions. Individuals with ASD are able to better navigate transitions when they
know what is coming next. Schedules make use of visual information (via picture or text) to help
the individual know what is coming next, understand first/then concepts, and incorporate choice
into the daily schedule of required activities. Use of schedules varies widely depending on the
individuals’ abilities and needs. Schedules may be as simple as placing the corresponding
picture/text in a designated place to signal the beginning and/or end of an activity, pointing to
provide cues for what comes next, removing the cue when the task is completed, or placing the
picture in a “done” pile (NAC, 2015). Schedules are often incorporated into other interventions.
Scripting
Scripting involves developing a scenario (often written) to assist an individual in verbally
responding to certain social situations. Scripts target specific skills or situations (e.g., asking for
help or for a break) that is practiced repeatedly before the skill is used in an in vivo, real-life
situation. These methods are generally used in tandem with other behavioral interventions. In
order to use scripting, the individual must have prerequisite reading and/or imitation skills. The
end goal is to eventually fade scripting and increase the variety and spontaneity of responses
(NAC, 2015).
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Self-Management
The goal of self-management is to increase independence in a given situation, particularly
in tasks where adult supervision is not usually needed or expected. Self-management involves
teaching the individual to be aware of, evaluate, and record their own performance while
engaging in an activity, and can be used to help monitor social and disruptive behaviors. The
process should include concrete criteria defining success, systematic methods for recording
performance (e.g., counters, checklists), adults who can provide feedback regarding accuracy of
recording and provide prompts during learning stages, and teaching the ability to independently
access reinforcers after meeting pre-established criteria. Self-management has primarily been
studied in adolescents and young adults (NAC, 2015).
Social Skills Package
Social skills encompass a large number of skills such as eye contact, joint attention, use
of nonverbal communication/gestures, reciprocal conversation or engagement in a social
exchange, and both initiating and ending an interaction. A number of similar social skills
packages exist; the goal of each is to increase the ability of an individual to participate in various
social settings by teaching necessary social skills. Packages typically include elements of
modeling, reinforcement and prompting, regardless of if sessions are one-on-one, in a peer dyad,
small group, or other social situation (NAC, 2015).
Story-Based Interventions
Story-based interventions target a specific behavior by using a written description of the
situations in which a specific response is expected. For example, stories may target perspectivetaking skills to teach an individual not to laugh when a peer gets injured or is crying.
Individualized stories are typically written from an “I” or “some people” point of view. Stories
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identify target behavior, situations in which behavior is expected, and likely outcome of
engaging in the target behavior (which often includes information about others’ expected
interpretations or reactions; NAC, 2015).
Emerging Interventions for Autism Spectrum Disorder
An emerging intervention is an intervention for which results of at least one study indicate
potential favorable outcome, but overall the intervention lacks a base of high-quality research
studies showing that the intervention is consistently effective in multiple independent trials.
Based on the available evidence, emerging interventions cannot yet be designated as reliably
effective or ineffective. Because more well established interventions are available, established
interventions should be the treatments of choice, and parents should generally be dissuaded from
relying too heavily on emerging interventions. Many emerging interventions exist, including but
not limited to: augmentative and alternative communication devices, developmental relationshipbased treatment, exercise, structured teaching, imitation-based intervention, initiation training,
massage therapy, music therapy, picture exchange communication system (PECS), reductive
package, sign instruction, social communication intervention, structured teaching, theory of mind
training, and technology-based intervention. Interventions from this list are often used in
conjunction with other strategies, such as using PECS for the individual to indicate a need or
choice. Assessment of their efficacy may be complicated by their inclusion in a treatment
program using established practices (NAC, 2015). However, at this point treatments in the
“emerging interventions” category are not independently considered to be evidence-based
practices.
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Unestablished Interventions for Autism Spectrum Disorder
Unestablished interventions have little to no evidence to support them in the scientific
literature, and thus no firm conclusions can be drawn regarding effectiveness. For some
interventions, multiple studies consistently disconfirm efficacy, and yet the treatments continue
to be used by caregivers and even popularized by medical professionals. Many of the
unestablished ASD interventions are relatively benign other the hassle involved (e.g., gluten-free
diets) and possible high cost (e.g., auditory integration), but some unestablished interventions are
potentially harmful. Unestablished interventions are bountiful, including but not limited to:
animal assisted therapy, auditory integration training, concept mapping, floor time, facilitated
communication, gluten-free/casein-free diet, movement-based intervention, theater intervention,
sensory integration/sensory intervention package, shock therapy, social behavioral learning
strategy, social cognition intervention, dietary supplements, acupuncture, homeopathy, and more.
Some of these practices, such as gluten- and casein-free diets, are widely held to be efficacious
by parents (Winburn et al., 2014) although the two large randomized clinical trials that tested
their efficacy failed to show any positive effect (Elder et al., 2006; Knivsbert, Reichelt, HØien,
& NØdland, 2002). Reports of using dietary supplements (e.g., omega 3 fatty acids) are
becoming more frequent, despite little scientific understanding of potential aversive effects of
interactions between medications and many of the reported supplements (Levy & Hyman, 2008).
Some actions touted as interventions for ASD not only have little evidence of efficacy,
but also carry significant risk of harm. These practices are not mentioned in the National
Standards Project report, but chelation therapy (an invasive procedure that is medically indicated
for confirmed heavy metal poisoning) and hyperbaric oxygen therapy (medically indicated to
treat decompression sickness in scuba divers, or to treat wounds resistant to healing as a result of
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diabetes or radiation injury) have been advertised as potential treatments or even cures for ASD.
These invasive procedures place individuals at considerable risk, and yet some desperate (and
perhaps ill-informed) caregivers have shelled out thousands of their own dollars chasing the
chimeric “cure” for ASD. Some children have lost their lives as a result (Baxter & Krenzelok,
2008; Brown, Willis, Omalu, & Leiker, 2006), thus underscoring the importance of
understanding the factors underlying which treatments caregivers pursue and which interventions
are eventually secured.
Who Gets Which Services?
In the body of literature surrounding EBP and non-EBP, a common phrase used to
describe non-EBP is complimentary or alternative medicine (CAM). CAM approaches consist of
various interventions not empirically validated for use in treating ASD. Interestingly, use of
CAM approaches does not seem to be lessened with greater access to conventional treatments;
rather, CAM use has been positively associated with receipt of 20 or more hours per week of
conventional behavioral treatment (Akins, Krakowiak, Angkustsiri, Hertz-Picciotto, & Hansen,
2014). Approximately half of caregivers of children with ASD in the US report use of CAM
(Golnik & Ireland, 2009). Salomone and colleagues (2015) found a strong dose-response effect
of use of conventional treatment and the concurrent use of mind/body CAM practices; parents
who were using more than four conventional treatments were four times as likely to concurrently
use CAM. This was not the case for those parents who used three or fewer conventional
interventions (Salomone et al., 2015).
Salomone and colleagues (2015) found approximately half (47%) of caregivers reported
having used complimentary or alternative medicine (CAM) approaches to treat their children
with ASD. Twenty-five percent of caregivers reported using dietary restrictions and/or
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supplements, with another 24% of caregivers reporting use of mind/body practices such as
sensory integration (14%), massage (7%), and homeopathy (10%). Pet therapy was endorsed by
14% of caregivers (Salomone et al., 2015). The researchers found that 2.4% of parents endorsed
using any “invasive, disproven, or potentially unsafe CAM” including chelation, hyperbaric
chamber, and packing (being wrapped tightly for up to an hour in wet sheets that have been
refrigerated).
Salomone and colleagues (2015) found that predictors of dietary restriction and/or
supplements included higher parent education level, low verbal ability in the child, and the use of
prescription medications; child’s age, gender, or concurrent use of EBPs were not associated
with increased likelihood of dietary restrictions or supplements. Mind/body practices including
acupuncture, deep pressure therapy, massage, sensory integration therapy, and auditory
integration therapy were more likely to be used by highly educated parents to treat female
children with ASD; age, verbal ability, and concurrent use of medication were not associated
with increased likelihood (Salomone et al., 2015). The finding that caregivers with higher
education are more likely to use CAM is in concordance with previous research (Akins,
Krakowiak, Angkustsiri, Hertz-Picciotto, & Hansen, 2014; Bernier, Mao, & Yen, 2010). While
caregivers with higher educational achievement were more likely to use both types of
interventions, the difference in use between higher and lower educated parents was most striking
for mind/body interventions.
Parents with a higher educational level may be more likely to use CAM / non-EBP
simply because they are more likely to be able to afford them. Non-EBPs are not generally
funded by insurance, and many involve direct provision of the therapy by the provider (e.g.,
massage, acupuncture, auditory integration), thus incurring substantial cost. These therapies are
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on average approximately double the cost of dietary supplements and other interventions that
parents can administer (Nahin, Barnes, Stussman, & Bloom, 2009). In conclusion, the use of
unestablished treatments (CAM) is common, usually in concert with one or more conventional
ASD treatments (generally behavioral EBP, though types and definitions vary from study to
study). Some factors are more predictive of one type of CAM use versus another, and a small
minority of caregivers continues to pursue unsafe or dangerous practices despite active public
campaigns against their use (Federal Drug Administration, 2014).
Many primary care physicians of children with ASD report conversing with caregivers
regarding biologically based CAM, such as dietary supplements (Golnik & Ireland, 2009). In a
survey of 539 physicians, Golnik and Ireland (2009) found primary care physicians treating
children with ASD encouraged the use of multivitamins (49%), essential fatty acids (25%),
melatonin (25%), and probiotics (19%), and discouraged withholding (76%) or delaying (55%)
immunizations, chelation (61%), and secretin (43%). Many of the physicians in this survey
reported a desire for additional training on available ASD treatments. This is promising as a
focus for advancing accurate information regarding various therapies and relative risk/benefit
ratios. Professionals who work with individuals with ASD should recognize the likelihood that
many of their clients are using CAM concurrently with EBP, and engage caregivers in
discussions about CAM approaches, current state of the evidence, and potential for adverse
effects as parents make treatment choices.
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CHAPTER 4: BARRIERS TO ACCESSING ASD INTERVENTIONS
Community and Cultural Factors
Ethnicity may impact both the likelihood of receiving an ASD diagnosis and the age at
which that diagnosis is given; these factors in turn may affect access to services and insurance
eligibility. Differences in service use by individuals from minority racial or ethnic backgrounds
have been found in multiple studies. Latino or African American children with ASD are less
likely to receive a diagnosis or to be diagnosed at a later age, thus missing out on important
opportunities for early intervention to affect developmental trajectories (Mandell et al., 2009). In
the Mandell et al. (2009) study, African American children were diagnosed an average of 1.4
years later than Caucasian peers. Black / African American children may be more likely to be
misdiagnosed than non-Latino white children. Mandell et al. (2009) found that black children
were three times more likely to receive a different diagnosis, most often conduct disorder, before
eventually receiving an ASD diagnosis. In this same study, Mandell and colleagues found that
children of other minority groups, many of whom were recent immigrants, were more likely to
be diagnosed with adjustment disorder before eventually receiving an ASD diagnosis. It is easy
to conjecture that a diagnosis of conduct disorder or adjustment disorder would lead to very
different types of intervention than if the child had initially received ASD diagnosis.
Latino children are less likely to receive an ASD diagnosis than white non-Latino
children (Liptak et al., 2008; Mandell et al., 2007; Palmer et al., 2010), and those who are
diagnosed receive a diagnosis on average 2.5 years later (Mandell et al., 2002). Recently, Palmer
and colleagues (2010) found that a 10% increase in the number of Latino children in a school
district correlated with an 11% decrease in ASD diagnoses, but an 8% increase in ID diagnoses.
These researchers contrariwise found that a 10% increase in non-Latino white children
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corresponded with a 9% increase in ASD but an 11% decrease in ID (Palmer et al., 2010).
Zuckerman et al. (2014) conducted focus groups with Latina mothers of Mexican origin to
discuss perceived barriers to receiving timely diagnosis, and participants reported several cultural
or community-specific factors. Parents stated that in their Mexican communities, the concept of
ASD was practically non-existent, so a child who exhibited stereotypical ASD symptoms might
be seen as being poorly behaved and unintelligent but without medical diagnosis (Zuckerman et
al., 2014). Because unusual and potentially disruptive behaviors are not understood as being
related to a disorder, the child’s behaviors may be seen as particularly shameful and indicative of
poor parenting. Parents in this study also recalled significant stigma in their communities
surrounding disabilities, particularly those related to mental health (Zuckerman et al., 2014). One
mother recounted that in her hometown in Mexico, “parents ignore their children if they have
some disability. . . If they are born with a deformed ear, they say, ‘this child isn’t worth
anything,’ . . .or if they have a child in a wheelchair [and] . . .the mother goes outside the house
to talk with someone selling something, she closes the door so no one can see him” (Zuckerman
et al., 2014, p. 304). Due to a lack of awareness of ASD, fear of being seen as a poor
disciplinarian, and disability stigma, some parents reported feeling uncomfortable admitting or
sharing their concern about their child’s behavior (Zuckerman et al., 2014). Some mothers
reported machismo, traditional view of Latino male gender roles, as a particular problem for their
partners. Mothers noted some fathers felt having a “weak” or “disabled” male child was a poor
reflection on themselves, thus fathers might discredit mothers’ expressed concerns (Zuckerman
et al., 2014). This could conceivably lead to disagreement about pursuing diagnostic services and
lead to delays in treatment. While this study focused on a narrow range of participants (mothers
of Mexican background), there are many areas of the world where the concept of autism is
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nascent or entirely absent, as in many African countries (Ruparalia et al., 2016). Wherever there
is a lack of understanding of ASD, there exists a risk of misconceptions about the etiology or
significance of unusual behaviors to impede appropriate diagnosis and treatment.
Unsurprisingly, language barriers present a significant obstacle to receiving timely ASD
diagnosis in the United States when parents are not fluent in English. Limited English
proficiency contributes to difficulties with scheduling appointments and arranging transportation;
limited access to qualified interpreters make it difficult for parents and clinicians to fully
communicate and for parents to navigate the often multi-step diagnostic process (Zuckerman et
al., 2014). In Zuckerman et al.’s (2014) study, Latina mothers reported concern that lessacculturated parents are often afraid to speak up for fear of being seen unfavorably; these parents
also may not know their child is eligible for certain services for which they could advocate, or
that supportive services such as assistance with transportation to and from appointments are
available. It is also possible that in families where one or more members are undocumented
immigrants, caregivers may be wary of getting involved in the diagnostic process or the pursuit
of public insurance for the child despite reassurances of confidentiality due to concerns about
how records may be accessed or used.
Ethnicity impacts not only diagnostic but also treatment service access. In a study of 383
families in North Carolina, Thomas and colleagues (2007) found racial and ethnic minority
families had only half the odds of using a case manager and a quarter the odds of using a
psychologist or developmental pediatrician as part of their child’s treatment. Rosenberg, Zhang,
and Robinson (2008) found that in the United States, black children are only half as likely as
white peers to receive early intervention services. Zuckerman et al. (2014) found that Latina
mothers reported purposefully avoiding seeking out services after an ASD diagnosis because the
25

diagnosis was so stressful and families had to adapt to the idea of the diagnosis before feeling
ready to move on to the next step of accessing treatment. Reported stress from adjusting to the
ASD diagnosis was related to the sense of stigma in having a child with a developmental
disability (Zuckerman et al., 2014). While there has been an increase in research into ethnic
factors related to ASD treatment in the past few years, overall there is a limited representation of
ethnic and cultural minority participants in the research literature, especially pertaining to
evidence-based interventions (West et al., 2016).
Socioeconomic Status and Financial Barriers
Despite state and federal efforts to make assessment and early intervention services
accessible regardless of SES, differences still exist. Durkin et al. (2010) found that those in the
lowest third SES were half as likely to receive an ASD diagnosis as those in the highest third
(Durkin et al., 2010). Interestingly, these statistics held true regardless of whether SES was
measured by percent household income above poverty, parental educational attainment, median
household income, or some combination (Durkin et al., 2010). Thomas et al. (2007) found that
when parents had at least a college degree, families were 2-4 times more likely to use a
neurologist, Picture Exchange Communication System (PECS), or therapeutic horseback riding,
but overall no strong differences were noted in treatments used.
Poverty exacerbates difficulties in receiving assessment services both directly and
indirectly. According to one report, a child with ASD incurs approximately seven times greater
health care costs than a child without ASD (Liptak, Stuart, & Auinger, 2006). Medical and nonmedical care costs for children with ASD are higher than costs for children with other
developmental disabilities (Croen, Najjar, Ray, Lotspeich, & Bernal, 2006; Liptak, Stuart, &
Auinger, 2006), particularly for children who do not have a medical home coordinating the care
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(Kogan et al., 2008). Sharpe and Baker (2007) found that having a lower income was positively
associated with having unreimbursed medical or therapy expenses, greater use of medical
interventions, and forfeiture of future financial security (e.g., retirement, savings accounts). Even
if insurance coverage is adequate, additional financial costs may be incurred due to the necessity
of securing transportation, finding childcare for other children, or loss of hourly wages if
caregivers must take time away from work. A child with ASD may require specialized care that
excludes him/her from typical childcare settings, and may result in the necessity of one or both
parents reducing work hours or one parent quitting a job (Gould, 2004). In a study of children
with severe disabilities (a category including severe ASD symptomatology), Leiter et al. (2004)
found that 20% of the caregivers sampled provided 20 hours per week or more of specialized
health care themselves; half of the employed mothers had reduced work hours and half of nonemployed mothers had quit work in order to meet their child’s needs.
Insurance
Lacking insurance or having inadequate insurance coverage imposes a financial burden
for accessing many services. Data from national surveys, private health insurance claims,
managed care organizations, and state Medicaid programs point to a high rate of health care
utilization by children with ASD, even when compared to children with other types of
developmental disorders (Chatterji, Decker, & Markowitz, 2015). Utilization is especially high
for psychiatric services and prescription medications (Chatterji, Decker, & Markowitz, 2015).
Given that treatment plans for ASD tend to be multidimensional and highly individualized
depending on the child’s symptom constellation and severity, treatment plans are often quite
costly (Amendah et al., 2011). Comparing children with and without ASD using data from the
Medicare Expenditure Panel Survey and National Health Interview Survey, Lavelle and
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colleagues (2014) found that after controlling for demographic factors and comorbid illnesses,
children with ASD incurred an average of $3,020 additional health care costs and $14,061
additional non-healthcare costs annually (including $8,610 additional school-related costs). It is
noteworthy that this study was of children who were enrolled in Medicaid. The caregivers of
children with ASD did not report significantly higher out-of-pocket costs or report spending
more time on caregiving activities compared with the control group (Lavelle et al., 2014). It is
possible that parents of children with private insurance have similar experiences, but no
comparable studies across different private insurance providers are evident in the literature at
present.
Caregivers of children with ASD have reported greater challenges in accessing services
and less overall satisfaction with services rendered when compared to caregivers of children with
other special health care needs (Montes, Halterman, & Magyar, 2009). Insurance plans generally
exclude some types of ASD treatments, especially behavioral treatments (Chatterji, Decker, &
Markowitz, 2015), even though several behavioral treatments are efficacious for treating ASDrelated challenges (NAC, 2015). With many states having recently mandating ASD coverage for
most insurance plans, these exclusions are fortunately on the decline, though extent of
reimbursement may still be quite limited.
Thomas et al. (2007) surveyed 383 families of children with ASD, and found that
children covered by Medicaid or other public insurance had 2 to 11 times the odds of using the
following compared to children covered by private insurance: medication management,
therapeutic support services including respite care and case managers, Picture Exchange
Communication System (PECS), and speech/language therapy. These same children were only
one quarter as likely to use dietary supplements as those on private insurance. Perhaps
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surprisingly, children who lacked health insurance were more likely to receive services that
facilitated entry into the health care system (e.g., case manager, developmental pediatrician;
Thomas et al., 2007). More recently, Parish and colleagues (2014) found that on average,
families of children with ASD spent approximately 4.1% of income per capita on their child’s
health care. After controlling for symptom severity and demographic characteristics, families
with private insurance were more than five times as likely to have out-of-pocket expenditures for
ASD treatment compared to families of children covered by public health insurance. The most
frequently cited out-of-pocket costs were medications, outpatient services, and dental care
(Parish, Thomas, Williams, & Crossman, 2014). The disparities between private and public
insurance in these studies indicate significantly greater financial burden for children covered by
private insurance.
To ease the financial burden of ASD, now recognized as the second-most common
developmental disability in childhood (behind intellectual disability; Newschaffer et al., 2007),
many states have recently mandated insurance coverage of ASD-related services. As of
September 2015, 42 states have passed laws that require many private health insurance policies
to include diagnostic and treatment services for ASD (American Speech-Language-Hearing
Association, 2015). It is unclear how efficacious these mandates have been in reducing out-ofpocket expenses or expanding access to treatment as very little data has yet been published on
the effects. Johnson, Danis, and Hafner-Eaton (2014) studied the variation of insurance coverage
across the United States of America at a time that 30 of the states mandated private insurers to
cover behavioral therapy for autism. The authors found that rather than decreasing the disparity
in service accessibility between states, the states that had passed insurance mandates at that time
were those in which services were already more readily available prior to the new legislation
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(Johnson, Danis, & Eaton, 2014). The authors concluded that the mandates resulted in an
increase in the disparity in service accessibility between more advantaged and less advantaged
states. In a study of the 37 states with ASD insurance mandates at the time, Chatterji and
colleagues (2015) found ambiguous results regarding the mandates’ effect in reducing out-ofpocket spending and increasing access to services; no statistically significant association between
state ASD mandates and caregiver report of financial burden, access to care, or unmet need for
services was found. The authors noted that the effect of such a mandate likely varies state to state
based on the percentage of the working population included, and further research is needed in
this area.
Geography
Geographical location also factors into the likelihood of a diagnosis and access to
services. As an example, Louisiana’s Office for Citizens with Developmental Disabilities
acknowledged geographical disparities in ease of access to services provided by its statewide
early intervention program for toddlers with developmental delays. Despite considerable efforts
to reach all areas of the largely rural state, OCDD reported concern over a shortage of providers
in particular disciplines, as well as a shortage of providers in general in rural areas (OCDD,
2013). This is only one example; other states likely experience similar difficulties in providing
services with equanimity in the face of financial restrictions and uneven distribution of qualified
providers across regions.
Urban areas with greater density of medical professionals and with closer proximity to
medical services may have an advantage in providing diagnostic and treatment services, thus
mitigating the effect of some other factors often associated with variability in service access. For
example, a population-based study conducted by the CDC in urban Atlanta found no influence of
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race, ethnicity, or sex on the age of diagnosis, but that age of diagnosis was affected by degree of
impairment (Wiggins, Baio, & Rice, 2006). In this study, children with ASD were initially
evaluated at an average of 48 months and received a diagnosis 13 months later (Wiggins, Baio,
& Rice, 2006). Kalkbreener et al. (2011) found similar results, with the majority of children
living in urban areas having better access to services and receiving diagnoses at an earlier age.
Thomas et al. (2007) found that when families lived in nonmetropolitan areas, children with
ASD had reduced odds of two treatments in particular: attending summer camp (Odds Ratio =
0.33), and using respite care (Odds Ratio = 0.21).
Systemic Barriers
Possible barriers at the systemic level may include failure to incorporate appropriate
screenings into pediatric wellness visits, reluctance of pediatricians to refer young children, or
children with less severe symptoms, or lack of coordination between various agencies. Children
in child protective services, or otherwise part of child welfare systems, are often under-identified
with regard to developmental delays including ASD (Berkoff, Leslie, & Stahmer, 2006). The
number of pediatricians available in a given area may play a role in identifying rates of ASD
(Mandell & Palmer, 2005), as do medical and educational system funding levels, which affect
ability to train providers (Mandell & Palmer, 2005). Sices et al. (2004) found that the type of
behavior exhibited in the pediatrician’s office had a greater influence on determining referral for
diagnostic services than did parents’ initial concerns about their child’s development, including
day to day behavior at home. In this same study, female medical doctors were more likely than
males to refer a child to a specialist for evaluation (Sices et al., 2004).
Zuckerman et al. (2014) found that many Latina mothers reported losing faith in
healthcare providers throughout the diagnostic process, which was often described as lengthy
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and intensely stressful. Declining trust in the healthcare system was related to length of time over
which the diagnostic process extended; mothers reported that as time went on they began
doubting whether providers were delivering care in the best interest of the child, and wondering
if providers were purposefully increasing the difficulty of service access (Zuckerman et al.,
2014). Some mothers reported feeling as if the diagnostic visit was primarily for conducting
research, rather than for providing thoughtful recommendations or helpful resources. The results
of Zuckerman et al.’s (2014) study fit with research reports that ethnic minority families receive
less guidance and experience increased obstacles when pursuing heath care in general (Jimenez,
Barg, Guevara, Gerdes, & Fiks, 2012; Zuckerman, Perrin, Hobrecker, & Donelan, 2013).
Distrust in the medical system could erode a caregiver’s willingness to continue on despite the
stresses of navigating the healthcare system in pursuit of treatment.
Characteristics of Early Intensive Behavioral Intervention (EIBI)
Sometimes the very nature of the intervention presents barriers to participation, such as
the time demands and often-intrusive nature of in-home EIBI. EIBI is, by definition, intense in
nature, often multiple hours per day for most days of the week. Although EIBI is widely
recognized as one of the most fruitful interventions for young children with ASD, and likely
results in better prognosis and cost savings in the long term, in the short term these programs are
very expensive (up to $30,000 per year; Sharpe & Baker, 2007). Many insurance policies will
not pay for the entire 20-40 hours per week that these programs generally recommend.
Accordingly, providing EIBI for a child with ASD often imposes great financial burden on
families, even those with medical insurance. EIBI services are often delivered in the individual’s
home, though they may be provided at a school or therapy center. When they are provided in the
home, several therapists may regularly frequent the home; this may present a problem for some
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families who highly value privacy. Scheduling constraints may be problematic if a primary
caregiver is required to be home during all therapy hours.
Johnston and Hastings (2002) analyzed barriers to the implementation of ABA-based
EIBI programs for ASD, concluding that barriers experienced by families fell into the following
categories: characteristics of particular service providers (e.g., policies, lack of resources, long
wait lists) or their staff (e.g., lack of training and skill), the nature of the programs (e.g., slow to
produce noticeable change, perceived inflexibility), and external factors (e.g., family factors).
The researchers found that the largest percent (70.9%) of 141 families of children with ASD
reported difficulty developing or maintaining a treatment team; these families perceived that
problems with staff shortages or lack of appropriate training for staff constituted a significant
barrier. Of note, this study was conducted in the United Kingdom at a time when ABA-based
programs were relatively new to the ASD treatment scene. The authors noted a paucity of welltrained supervisory staff, which they conjectured may not be as large a barrier in the United
States where EIBI has been widely promoted for a longer period of time (Johnston & Hastings,
2002). Other common barriers to implementing intensive behavioral intervention included
difficulty in funding services (68.1%); and personal/family constraints such as amount of time
required, scheduling around other family members, or other obligations (42.6%). Johnson &
Hastings’ (2001) list of perceived barriers to EIBI also included problems with educational
systems such as negative attitudes or unwillingness to provide services (17.7%), negative impact
on families such as disruption of family life or feeling that home space was invaded (13.5%),
lack of support from specific schools or teachers (9.2%), child-specific concerns such as illness
or lack of concentration (5.7%), and lack of physical resources (e.g., necessary equipment or
space) in home (5.0%; Johnson & Hastings, 2001). In this same study of barriers to ABA-based
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early intervention programs, Johnson and Hastings (2001) found that facilitators of participation
in ABA-based programs included perceptions of having a stable, supportive care team (75.9%);
being motivated by observable progress (26.2%); flexible work schedules (4.3%), and a number
of other factors falling broadly under “social support” (e.g., support of family, friends, support
groups, and/or school faculty).
Comorbid Conditions
ASD used to be considered as a singular condition; however, research has evolved our
understanding of etiology of autism, and researchers have demonstrated that ASD commonly
occurs with other psychopathology (Matson & Nebel-Schwalm, 2007; Smith & Matson, 2010a,
2010b, 2010c). Children with ASD have a high rate of other mental and physical difficulties,
with some estimates as high as 80% or more having psychiatric comorbidity (Joshi et al., 2010;
Kogan et al., 2009; Matson & Nebel-Schwalm, 2007). In a study of families of children with
ASD only and children with ASD plus a comorbid psychiatric condition, Ahmendani and Hock
(2012) found higher overall healthcare utilization among the 66.2% of participants with
comorbid conditions, but these families were also more likely to be dissatisfied with care,
dissatisfied with coordination between providers, and to report delay or non-receipt of needed
services. Delay or non-receipt of services was most likely for children with comorbid depression
or conduct problems. The most frequently cited reasons for delaying or not receiving treatments
among those with comorbid conditions were out-of-pocket cost and denials of coverage by
insurance. Delays were also likely when parents perceived that providers did not communicate
effectively with the parent and did not make the parent feel like a partner in care (Ahmendani &
Hock, 2012). Children with comorbid conditions may be more likely to need services from
multiple locations, contributing to the challenges of coordinating care among providers, and
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paying via multiple sources (e.g., public, private, self-pay). The increased challenges to receiving
care in Ahmendani and Hock’s (2012) study provide evidence that the existence of comorbidities
predisposes one to experience greater challenges in meeting health care needs, but does not
provide a direct link between the presence of a comorbid condition acting as the limiting factor
in receiving treatment. However, it is not difficult to imagine scenarios in which challenging
behavior could be prohibitive to intervention. For example, a child who becomes very aggressive
when angry or engages in unsafe behaviors in the car may cause parents to second guess their
ability to safely take their child to the session, or weigh the long-term gains against the shortterm struggles.
Burden of ASD Diagnosis
The process of obtaining an ASD diagnosis can be complex and time-consuming; once a
diagnosis is given, parents and caregivers face additional future stressors related to navigating
health, educational, and other service systems for their child. The direct costs of medical and
nonmedical services plus indirect costs such lost opportunities and income for individuals with
ASD and their families have been estimated to total approximately $3.2 million per child in the
United States (Ganz, 2006). The emotional burden of caring for a child with ASD can be
significant for the entire family. Compared to families of children with ASD, families of children
with special health care needs (CSHCN) who do not have an ASD diagnosis are significantly
less likely to report problems with referrals, coordinating care, and obtaining family support
services (Kogan et al., 2008). Parents must often shoulder the burdens of physical and emotional
stress, divorce, and job loss, which then impact the entire family system (Baker-Ericzen,
Brookman-Frazee, & Stahmer, 2005; Bromley, Hare, Davison, & Emerson, 2004; Hastings et al.,
2005; Järbrink, Fombonne, & Knapp, 2003).
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Early identification can lead to better outcomes for children and families if identification
leads to receipt of appropriate intervention services and supports for the family (Council on
Children with Disabilities, 2006), but when parents have to act as coordinators for intervention
services across several disconnected systems (healthcare, education, social services, transition
services upon starting school and aging out of child-focused services), there are many potential
barriers that can stymie the parents’ efforts. Investigating the difficulty of coordinating care,
Carbone, Behl, Azor, and Murphy (2010) noted that pediatricians reported little to no dialogue
with school systems for the purposes of developing intervention plans. The researchers noted
lack of uniform eligibility requirements for interventions that were not integrated across the
several different systems serving the family. “This lack of coordinated care,” they stated, “results
in confusion for families, mixed messages from different treatment providers, and promotes
adversarial relationships between various disciplines” (Carbone et al., 2010, p. 322). Woodgate,
Ateah, and Secco (2008) found that many parents described their contact with various systems as
patently unsupportive. Thomas, Ellis, McLaurin, Daniels, and Morrissey (2007) found that
parents who reported greater family stress were more likely to engage in intervention services.
Other researchers have found that the struggle to access services is a significant stressor for
families of children with autism, due to a variety of barriers including financial cost and limited
availability (Mackintosh, Goin-Kochel, & Meyers, 2012).
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CHAPTER 5: PURPOSE
Disparities in service use indicate a need to develop policy, practice, and family-level
strategies to address barriers to ASD services. Research about how families experience diagnosis
and coordination of intervention services, along with perceived barriers and facilitators, can
inform the development of efforts to this end. Federal and state policies and practices within
service systems will be better able to improve with understanding of their clients’ experiences.
The goal of this study is to investigate current patterns in perceived barriers experienced in
accessing both diagnostic and intervention services, including the most significant barriers
associated with evidence-based interventions.

37

CHAPTER 6: METHOD
Participants
Inclusion criteria for this study included self-identified caregivers of individuals with an
ASD diagnosis (Autism Spectrum Disorder, Asperger’s Disorder, PDD-NOS, or Autistic
Disorder) who completed an online survey (see Appendix A) and reside in the United States of
America. Participants were recruited through information distributed to health care clinics,
parent advocacy/support groups, outpatient therapy clinics, and similar organizations. A total of
150 individuals began the online survey. Participants were excluded from analyses for the
following reasons: Selected “Decline to participate” after reading introductory page and
confidentiality information (n = 1), dropped out during initial demographics questions (n = 58),
diagnosis listed as something other than ASD (i.e., “sensory processing disorder,” (n = 2), or
misunderstanding the questionnaire (n = 1) in the case of an employee at a residential center who
attempted to complete the survey about multiple clients in general rather than a single
individual). This left a total of 88 participants to be included in analyses, with a dropout rate of
42.33%. This is somewhat higher than the roughly 30% dropout rate often observed in shorter
online surveys (Galesic, 2006), but Galesic found a similar dropout rate for a similar study of
41.8% for an online survey without compensation of similar length (180 questions) in a study of
effects of interest and burden affecting dropout rates on online surveys. It is likely that a shorter
survey would have had a higher completion rate, but the completion rate is within the expected
range given the characteristics of the survey.
The 88 participants whose data were retained for analysis reported residing in 20
different states, with the states most frequently represented including South Carolina (n = 18),
Louisiana (n = 9), Pennsylvania (n = 8), and Indiana (n = 6). The majority of participants were
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parents (69 mothers, 5 fathers) or grandparents (n = 7) of individuals with ASD; other
participants included miscellaneous caregivers, generally other relatives (n = 6). Demographic
information for the caregiving participants and families is presented in Table 1. Breakdown of
participants by research question can be found in Appendix D, as not all participants were
included in all questions for various reasons (e.g., dropout, had not begun receiving treatment
yet, etc.).
Table 1. Demographic Information for Caregivers and Families (N = 88)
Demographic
n (percent)
Caregiver’s Ethnicity
White
75 (85.23)
African American
4 (4.54)
Latino
1 (1.13)
Asian
2 (2.26)
Other
0 (0.00)
Combination
4 (4.54)
Declined Answer
2 (2.26)
Child’s Ethnicity
White
70 (79.54)
African American
4 (4.54)
Latino
1 (1.13)
Asian
0 (0.00)
Other
2 (2.26)
Combination
10 (11.36)
Declined Answer
1 (1.13)
Caregiver’s Gender
Male
6 (6.81)
Female
81 (92.04)
Decline Answer
1 (1.14%)
Child’s Gender
Male
68 (77.27)
Female
4 (4.54)
Reported Diagnosis
Autistic Disorder
18 (20.45)
PDD-NOS
12 (13.64)
Asperger’s Disorder
7 (7.95)
ASD
51 (57.95)

39

Measures
Survey
An online survey was conducted to collect all required information from participants.
After informed consent was given, the second page of the survey took the participant to a page
with questions about demographic information. Questions included demographic information for
both caregiver and child, questions surrounding diagnostic and treatment service use and access,
and a measure of autism symptom severity (the Autism Spectrum Disorder-Diagnostic for
Children). The survey was designed such that all questions must be answered before the
participant can go on to the next page to decrease likelihood of missing data; however, “other,
write in” and “prefer not to answer” options were utilized in case participants found the provided
options to be insufficient.
Before recruitment for the study, a group of 8 parents served as a pilot group for the
survey. Three of these parents were primary caregivers for individuals with ASD and one was a
parent of a young child with special needs. Minor wording and formatting changes were made in
accordance with feedback from the pilot study prior to active recruitment. The survey was
designed in and administered through Qualtrics; see Appendix A for more detailed survey
information.
The first page of the online survey was the consent form, which informed participants
that information collected would be devoid of personally identifiable information (PII), outlined
measures to ensure data security, reminded participants that they could exit the survey at any
time by closing the survey window. They were also notified that they could withdraw all
previously entered data by contacting the researchers at the provided email, and provided the
email contact of the researchers and the LSU IRB in case any further information was desired.
40

The last page of the survey included information on what to look for when pursuing ASD
interventions, information on evidence based versus non-evidence based practices, and links to
reputable sources of information, followed by contact information for the researchers for any
follow-up questions.
Autism Spectrum Disorder-Diagnostic for Children (ASD-DC)
The ASD-DC (Matson & González, 2007) is a 40-item, informant-based rating scale to
assess ASD under the DSM-IV-TR diagnostic criteria. The ASD-DC was designed to be a costand time-efficient measure of symptoms associated with Autistic Disorder, Pervasive
Developmental Disorder Not Otherwise Specified (PDD-NOS), and Asperger’s Disorder, all
considered Autism Spectrum Disorders under the DSM-IV-TR criteria. It is the diagnostic portion
of a four-part assessment battery (the Autism Spectrum Disorder- Child Version; Matson &
Gonzalez, 2007 a, b, c); the full battery is designed to also assess comorbid symptoms and
problem behaviors in children ages 2-16 suspected of having an ASD. The battery also includes a
direct observation portion for the clinician to use in conducting a brief observational play session
with the child. For this study, only the caregiver report section assessing ASD symptoms, the
ASD-DC, will be used. In this measure, the clinician reads the items to caregivers, who are asked
to rate the items on a 4 point scale in which they compare the behavior of their child with the
behavior of typically developing, same-aged peers and rate the item for “extent that it is/was ever
a problem” as follows: 0 = “not different; no impairment”; 1 = “somewhat different; mild
impairment”; 2 = “very different; severe impairment.” Although typically the clinician reads
each item for this measure, for the purposes of this survey, caregivers will read each item
themselves as part of the survey.
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According to factor analysis, the ASD-DC measures behaviors on four factors
corresponding with areas impaired by ASD symptoms: nonverbal communication/socialization,
verbal communication, social relationships, and insistence of sameness/restricted interests
(Matson, Boisjoli, & Dempsey, 2009). Internal consistency of the measure is .99 and test-retest
and inter-rater reliability are satisfactory at κω=. 77 and κω=. 67, respectively (Matson,
Gonzales, Wilkins, & Rivet, 2008). The measure has good sensitivity and specificity to
diagnose ASD with total correct classification rates between typically developing children and
atypically developing children/possible ASD of 84.3%, and between atypically developing
children/possible ASD and children with probable ASD at 87.8% (Matson, González, &
Wilkins, 2009). Cronbach’s alpha for this particular sample was computed (40 items, α = 0.94),
with results indicating a high degree of internal consistency for this sample.
Procedure
Prior to participant solicitation, the research procedures and protocol were approved by
the Louisiana State University Institutional Review Board (see Appendix C for IRB approval).
Participants were recruited via posts to electronic forums (e.g., Facebook, Twitter, Reddit,
Postwaves, NextDoor), newsletters from state and regional Autism Society chapters, fliers posted
at a variety of places likely to be frequented by caregivers of children with ASD (e.g., doctor or
therapy provider offices, community centers), and word of mouth. An effort was made to
distribute across a wide geographic area (e.g., multiple states, national online forums),
particularly to organizations known to provide free or low-cost services (e.g., state organizations
that offer free/low cost diagnostic services to state citizens and treatment costs on a sliding scale)
in order to attract participants across a wider range of SES. Use of internet-only survey was
deemed appropriate due to rapid increases in internet access across demographics in recent years.
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According to a 2013 Pew Research study, only 15% of Americans do not regularly use the
internet; half of these individuals stated that they do not use the internet because it is “irrelevant
to them” rather than citing access/financial barriers. Based on past trends, it is likely that in the
three years since this study was published, an even greater percentage of individuals regularly
access the internet, and that internet access would not pose a significant barrier to completion of
this survey (Pew Research Center, 2013).
Recruitment information included inclusion criteria (i.e., primary caregiver of individual
with diagnosis of Autistic Disorder, Asperger’s Disorder, Pervasive Developmental Disorder not
otherwise specified, or Autism Spectrum Disorder) and a brief description of the type of
information sought (i.e., information related to treatments utilized, difficulty accessing services,
and demographic factors devoid of personally identifiable information). Recruitment
information stated that no compensation would be provided for survey completion and included
a link to the online survey. No incentive was offered due to inability to reliably screen out
participants who might complete the survey multiple times. Estimated time to complete the study
based on pilot testing was also included.
The information necessary for this study was collected via an online survey set up
through Qualtrics, a company with software by the same name used for online research data
collection and analysis. See Appendix B for detailed information regarding Qualtrics privacy
policies, certifications, and security measures. Louisiana State University currently has a contract
with Qualtrics, through which account the survey data was collected. After reading the consent
form, participants manually selected an acknowledgement button indicating they read and agreed
with the statements outlined in the consent form. Participants then completed the survey, which
collected the information outlined in Appendix A. Once data from a sufficient number of
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participants was collected, data was imported from Qualtrics into Statistical Package for the
Social Sciences (SPSS; IBM Corporation, 2013) for analysis.
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CHAPTER 7: HYPOTHESES
A series of analyses were performed to address several research questions: What are the
most commonly reported perceived barriers to diagnostic services? What are predictors of
experiencing the greatest number of perceived barriers to diagnostic services? What are
predictors of professional reassurances and family factors as perceived barriers to diagnosis?
What are the most commonly perceived barriers resulting in discontinuation of previous
interventions? What are the predictors of reporting the greatest number of barriers causing
discontinuation of EPBs? What factors predict length of time between diagnosis and receiving
treatment for ASD? What interventions are currently most desired? Finally, what factors are
predictive of caregivers hoping to obtain EBP over non-EBP?
It was expected that wait list for diagnostic services would be the most commonly
reported barrier to diagnosis. It was hypothesized that living in an urban area, higher household
income, higher educational attainment, and greater ASD symptom severity would be correlated
with fewer reported barriers to diagnostic services, whereas identifying as an ethnic minority
would be correlated with an increase in barriers, perhaps in part due to correlation in the United
States between minority status and greater barriers to achieving higher education and income. It
was hypothesized that increased ASD symptom severity would correspond with a decreased
likelihood of perceiving professional reassurances as a barrier to diagnosis, and also
hypothesized that increased education of parents would also correspond with a decrease in
perceiving this barrier, as more educated parents may be better able to engage researching
symptoms prior to appointments, thus able to speak more precisely about their child’s symptoms
and ask more pointed questions about autism-specific concerns. Based on literature reviewed in
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the section on Community and Cultural Factors, it was hypothesized that ethnicity would impact
likelihood of perceiving caregiver disagreement as a barrier to diagnosis.
With regard to interventions, it was hypothesized that changes in eligibility would be the
most frequent cause of discontinuation for early intensive behavioral interventions due to the
nature of the state- and federally-funded programs to target children in early childhood and
younger to receive these subsidized services. With regard to EBP and non-EBP in general, it was
hypothesized that while out of pocket cost would be a significant barrier, it would be more
highly cited as a cause for discontinuation of non-EBP services due to decreased likelihood of
insurance reimbursement for such services. Similarly to hypothesized results for barriers to
diagnosis, it was hypothesized that lower household income would predict higher numbers of
reported barriers to EBPs. It was also hypothesized that rural indication would also be correlated
with higher number of barriers to EBPs, while higher ASD symptom severity would be
correlated with fewer barriers. With regard to gap between diagnosis and treatment, it was
hypothesized that ethnicity would be most highly correlated with a gap between diagnosis and
treatment, with minorities experiencing the greatest gap. With regard to desired future EBPs, it
was expected that the barriers would follow the same trends found for reasons for discontinuing
past EBPs, with cost being highly ranked as a barrier. It was also expected that difficulties with
scheduling would also rank highly, since many treatment centers operate during normal working
hours (9am-5pm) and it could be that services had not yet been accessed due to difficulty with
parent work schedules or interference of time required for desired therapies conflicting with
currently received services or school.
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CHAPTER 8: STATISTICAL ANALYSES
First, preliminary analyses were conducted to determine the sample size needed to
answer the research questions. Second, descriptive analyses were run to provide additional
demographic information (e.g., income, insurance type, education level of caregivers). The third
set of analyses included descriptive analyses of factors related to perceived barriers to diagnostic
services, followed by a multiple regression to investigate factors related to reporting a greater
total number of barriers to diagnostic services. The author was particularly interested in factors
predicting barriers that could potentially be addressed with targeted educational initiatives (e.g.,
education for healthcare professionals or families to address related barriers). Accordingly, a
logistic regression was run to investigate factors related to professional provider reassurances as
a reported barrier to diagnostic services. Chi-squared test was run to investigate whether
identifying as being of ethnic minority status was correlated with increased likelihood of family
disagreement as a barrier to diagnostic services.
The fourth set of analyses investigated barriers to previously tried interventions that
resulted in discontinuation of interventions. Descriptive analyses outline the discontinued
treatments and barriers experienced to EBPs and non-EBPs. Multiple regression was used to
investigate predictors of experiencing greater number of barriers resulting in discontinuation of
EBPs. As insurance coverage is closely related to the out of pocket costs of treatment, follow-up
testing via Kruskal-Wallis analysis was conducted to investigate the relationship between
insurance type and number of perceived EBP barriers reported.
Fifth, multiple regression was used to investigate whether various demographic factors
predicted variations in time between receiving a formal ASD diagnosis and treatment of ASD
symptoms.
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Sixth, the author inspected the answers of those participants who had indicated a current
desire to pursue additional interventions for their child with ASD. A total of 51 participants
indicated they were either in the process of gaining access or were preparing to soon attempt to
access additional interventions. Of these, 41 participants gave answers that could be categorized
into EBP or non-EBP practices. Descriptive analyses provided information regarding perceived
barriers to desired interventions. A binomial regression was utilized to inspect factors related to
whether a participant who desired additional services was seeking EBP vs. non-EBP treatments.
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CHAPTER 9: RESULTS
Preliminary Analysis
G*Power 3, a power analysis computer program (Faul, Erdfelder, Lang, & Buchner,
2007), was used to determine the sample size needed for the analyses with the greatest number of
planned variables (regression analyses on factors affecting number of perceived barriers
reported). A medium effect size of ƒ2 = 0.2, power of .80, and alpha of .05 were used. These
methods are conventional and accepted levels for use in psychological research for alpha and
power (Cohen, 1988; Hinkle, Wiersma, & Jurs, 2003). A medium effect size was also chosen
due to the widely varying results of studies investigating various factors associated with barriers
to ASD services. The power analysis indicated a minimum of 75 participants would be sufficient
for the planned analyses.
Descriptive Analyses
The first set of analyses provided descriptive information for the participants and their children
with ASD. The majority of participants lived in urban areas (50,000+ residents), and only 8
resided in rural areas (less than 2,500 people). The majority of the sample had family incomes of
70,000 or more and an unusual number had some graduate school education (n = 30; 34.10%).
Additional demographic details are presented in Table 2.
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Table 2. Additional Demographic Details (N = 88)
Demographic
n (percent)
Geography of Residence
Urban
38 (43.18)
Suburban
42 (47.72)
Rural
8 (9.09)
Family Income*
<10k
7 (7.95)
10k-25k
5 (5.68)
25k-40k
6 (6.82)
40k-55k
14 (15.91)
55k-70k
11 (12.50)
70k-100k
20 (22.73)
>100k
18 (20.45)
Declined Answer
7 (7.95)
Child’s Insurance Type
Private Only
30 (34.09)
Public Only
27 (30.68)
Private and Public
24 (27.27)
None
0 (0.00)
Not Sure/Declined
7 (7.95)
Caregiver Education
Some high school
2 (2.27)
High school graduate
5 (5.68)
Technical degree
8 (9.09)
Some college
13 (14.77)
College graduate
30 (34.09)
Some graduate school
2 (2.27)
Graduate degree
28 (31.82)
Caregiver Marital Status
Single
8 (9.09)
Married or Cohabiting 62 (70.45)
Separated/Divorced
14 (15.91)
Widowed
4 (4.54)
Not sure/decline
0 (0.00)
*k = $1,000 US Dollars
Mean ASD-DC scores ranged from 58-119 (M = 92.36, SD = 14.79). Of note, 20
individuals were out of the age range of 2-16 years for which the ASD-DC was normed.
Excluding these 20 individuals, total ASD-DC scores were virtually unchanged, ranging from
59-118 (M = 92.25, SD = 14.06).
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Current ages of participants’ children with ASD ranged from 1.5 years to 32 years (M =
11.49; SD = 6.52). Age at diagnosis ranged from 1 to 21 years (M = 4.70; SD = 3.87). Many
individuals (N = 24) reported their child began receiving therapy to treat ASD symptoms before
actually receiving a formal ASD diagnosis. Age at first treatment for ASD symptoms ranged
from 1 year to 18.5 years (M = 4.24; SD = 3.35). Four participants reported they have not yet
been able to access treatment services. Twelve individuals reported beginning treatment within
one month of receiving diagnosis. Of those who experienced a delay between diagnosis and
treatment, time delay ranged from one month to 31 months. (M = 5.42; SD = 7.36). Time elapsed
between diagnosis and completion of survey were computed to be used as a covariate in analysis
on discontinued treatments; time ranged from 0 months to 278 months (M = 80.27; SD = 70.89).
Additional information regarding ages and time delay is presented in Table 3.
Table 3. Age / Time Information
Occasion

N

In Months
M (SD)

In Years
M (SD)

Child’s Age:
Present
At Diagnosis
First Treatment*

88
88
84

137.93(78.27)
56.39 (46.45)
50.90 (40.16)

11.49 (6.52)
4.70 (3.87)
4.24 (3.35)

Time Lapse
Diagnosis to Treatment*
Gap Diagnosis to Treatment**
Diagnosis to Present

84
60
88

5.42 (7.36)
80.27 (70.89)

--6.70 (5.91)

*Excluded individuals who have not begun receiving treatment yet (n = 4)
**Excluded individuals who have not begun receiving treatment (n = 4) or began
receiving treatment prior to diagnosis (n = 23).
Perceived Barriers to Diagnostic Services
Descriptive Analyses
The most frequently reported perceived barriers to diagnostic services were long
waitlists, reassurances from professionals that the child would “grow out of it” or that symptoms
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were due exclusively to some comorbidity (e.g., intellectual disability, Down Syndrome, partial
agenesis of the corpus callosum), and difficulties with scheduling. Out of the 88 participants, 75
reported experiencing at least one barrier to receiving diagnosis. Many families experienced
multiple barriers to diagnosis. Overall, caregivers reported a mean of 1.68 (SD = 1.38) perceived
barriers to diagnosis, with a range of 0-7 barriers experienced. Additional details regarding
barriers to diagnostic services can be seen in Table 4.
Table 4. Perceived Barriers to Diagnostic Services (N = 88)
Barrier
Percent
n
Wait list
49
55.68
Transport/Proximity
6
6.82
Scheduling
19
21.59
Cost
15
17.05
Family
14
15.91
Practitioner Reassurances
33
37.50
Other
12
13.64
None
13
14.77
Predictors of Greatest Number of Past Barriers
Multiple regression was used to investigate factors related to experiencing greater
numbers of perceived barriers to diagnostic services. Investigated factors included geography
(living in urban, suburban, or rural areas), family income, ethnicity (minority or not), caregiver
education level, and ASD-DC Total Score. All factors were entered simultaneously. As
previously noted, 20 of the ASD-DC scores were for individuals outside of the designed age
range (2-16 years). To account for this, the analysis was run both with and without these
individuals included. Results of both analyses are reported below.
All participants included. Overall, caregivers experienced a mean of 1.68 (SD = 1.38)
perceived barriers to diagnostic services. There was linearity as assessed by partial regression
plots and a plot of studentized residuals against the predicted values, and independence of
residuals as assessed by a Durbin-Watson statistic of 2.16. There was homoscedasticity, as
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assessed by visual inspection of a plot of studentized residuals versus unstandardized predicted
values. There was no evidence of multicollinearity, as assessed by tolerance values greater than
0.1. There was one studentized deleted residual greater than ±3 standard deviations for an
individual reporting 7 of 10 possible barriers to diagnosis (studentized residual = 3.51), but
inspection of the data point indicated no probable error in data entry or other reason for removal,
and leverage value of 0.112 was within the acceptable range so this data point was maintained.
There were no leverage values greater than 0.2, and were no values for Cook's distance above 1.
The assumption of normality was met, as assessed by P-P Plot.
The multiple regression model did not predict number of barriers in a statistically
significant way, F(6, 81) = 0.842, p = .542. R2 for the overall model was 5.9% with an
adjusted R2 of -0.10%, a negligible effect size according to Cohen (1988). None of the five
variables added statistically significantly to the prediction, p > .05. Regression coefficients and
standard errors can be found in Table 5. Correlation coefficients within the context of the
regression analysis can be found in Table 6.
Table 5. Summary of Multiple Regression Analysis: Barriers to Diagnosis (N = 88)
Variable
β
B
SEB
Intercept
1.70
1.19
Geography
-0.08
0.05
-0.18
Income
-0.05
0.10
-0.07
Ethnicity
-0.45
0.43
-0.12
Education
1.24
0.11
0.15
ASD-DC Total Score 0.01
0.01
0.02
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β =
standardized coefficient
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Table 6.Correlation Coefficients of Multiple Regression Analysis: Barriers to Diagnosis (N = 88)
Variable
partial
semipartial p
r
Geography
-0.13
-0.17
-0.17
0.12
Income
-0.01
-0.06
-0.06
-0.55
Ethnicity
-0.09
-0.12
-0.11
0.30
Education
0.09
0.13
0.12
0.25
ASD-DC Total Score 0.01
0.02
0.02
0.83
Excluding participants outside the ASD-DC range. This analysis excluded individuals whose
children with ASD were outside of the ASD-DC age range (2-19 years) at the time of survey
completion. This left a total of 68 participants for the following analysis, which is slightly lower
than the sample size recommended via a-priori G*Power analysis. All factors were entered into
the regression simultaneously.
Overall, caregivers reported experiencing a mean of 1.74 (SD = 1.48) perceived barriers
to diagnostic services for their child. There was linearity as assessed by partial regression plots
and a plot of studentized residuals against the predicted values. There was homoscedasticity, as
assessed by visual inspection of a plot of studentized residuals versus unstandardized predicted
values. There was no evidence of multicollinearity, as assessed by tolerance values greater than
0.1. Homoscedasticity was assessed via visual inspection of a plot of studentized residuals versus
unstandardized predicted values. There was one studentized deleted residuals greater than ±3
standard deviations for an individual reporting 7 of 10 possible barriers to diagnosis (studentized
residual = 3.29), but inspection of the data point indicated no probable error in data entry or other
reason for removal, and leverage value of 0.13 was within the acceptable range so this data point
was maintained. There was one leverage value greater than 0.2, with a value of 0.24, but
inspection of Cook’s distance fell within acceptable limits and the data participant was
maintained. There were no values for Cook's distance above 1. The assumption of normality was
met, as assessed by P-P Plot.
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The multiple regression model did not predict number of barriers in a statistically
significant way, F(5, 61) = 0.97, p = .455. R2 for the overall model was 7.3% with an
adjusted R2 of -0.2%, a small effect size according to Cohen (1988). None of the five variables
added statistically significantly to the prediction, p > .05. Regression coefficients and standard
errors can be found in Table 7. Correlation coefficients within the context of the regression
analysis can be found in Table 8. Of note, examination of correlation tables independent of the
regression analysis revealed that ethnicity was significantly correlated with the total number of
barriers to diagnosis (r = -0.2, p = .049).
Table 7. Summary of Multiple Regression Analysis: Barriers to Diagnosis (N = 68)
Variable
β
B
SEB
Intercept
2.67
1.56
Geography
-0.98
0.07
-0.15
Income
-0.08
0.13
-0.10
Ethnicity
-0.97
0.54
-0.23
Education
0.06
0.15
0.06
ASD-DC Total Score 0.00
0.01
-0.02
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β =
standardized coefficient
Table 8. Correlation Coefficients of Multiple Regression Analysis: Barriers to Diagnosis (N =
68)
Variable
partial
semipartial p
r
Geography
-0.12
-0.15
-0.14
0.25
Income
-0.07
-0.08
-0.08
0.53
Ethnicity
-0.20
-0.22
-0.22
0.08
Education
0.24
0.05
0.05
0.71
ASD-DC Total
0.01
-0.02
-0.02
0.86
Score
Predictors of Professional Reassurances as Perceived Barrier to Diagnosis
Descriptive analyses revealed that 33 (37.50%) of participants reported having received
reassurances from professionals (e.g., pediatricians) that assessment was not needed at the time
of parents’ expressed concerns. Binomial logistic regression was used to investigate factors
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related to likelihood of encountering these barriers including geography, income, ethnicity,
education, and ASD symptom severity.
Linearity of continuous variables with respect to the logit of the dependent variable
(reporting professional reassurances as a perceived barrier to diagnosis) was assessed using BoxTidwell statistic. Bonferroni correction was applied resulting in accepting statistical significance
of p = .005 (Tabachnick & Fidell, 2007). All continuous variables were found to be linearly
related to the logit of the dependent variable (practitioner reassurances). No outliers were
identified. The logistic regression model was not statistically significant, χ2(6) = 3.46, p = .750.
The model explained 5.3% (Nagelkerke R2) of the variance in whether professional reassurances
were experienced as a barrier and correctly classified 63.6% of cases. None of the predictor
variables were statistically significant. Specificity was 94.5% and sensitivity was 12.1%.
Additional details are presented in Table 9. As with the regression analysis for total number of
barriers to diagnosis, the regression was also run excluding those participants who were outside
of the age range for which the ASD-DC was designed. No significant differences from the below
results were noted, thus those results are not included here.
Table 9. Logistic Regression Predicting Professional Reassurances as Barrier to Diagnosis
Wald df
Odds 95% CI for Odds Ratio
B
SE
p
Ratio Lower Upper
Minority
-0.53 0.65
0.68
1
.408 0.59
0.17
2.08
Education
0.20
0.18
1.27
1
.259 1.22
0.86
1.72
Geography
0.44
2
.804
Geo (1)
-0.55 0.84
0.44
1
.510 0.11
0.11
2.98
Geo (2)
-0.45 0.83
0.29
1
.590 0.13
0.13
3.24
ASD-DC Total 0.02
0,02
1.29
1
.255 1.10
0.98
1.05
Income
-0.10 0.16
0.31
1
.580 0.92
0.92
1.25
Constant
-1.97 1.85
1.12
1
.289 0.14
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Ethnic and Familial Barriers to Diagnostic Services
Fourteen (15.91%) participants encountered disagreement among caregivers or other
family factors that impacted receiving first diagnosis. Chi-square test was implemented to test for
association between ethnic status (minority or majority) and likelihood of reporting family
factors as a barrier to diagnostic services. Due to one expected cell frequency less than 5,
Fisher’s exact test was interpreted. One of 13 participants who identify as ethnic minorities
(7.69%) and 13 of 75 self-identified white participants (17.33%) reported family disagreement as
a barrier to diagnostic service. This did not represent a statistically significant association
between ethnicity and familial barriers to diagnostic services, χ2(1) = .683, p = .343.
Perceived Barriers Resulting in Discontinuation of Previous Interventions
Of the 88 participants initially retained from analyses, four were excluded from questions
regarding treatment because they had not yet begun receiving treatment. Additionally, six more
were excluded because they dropped out of the survey after answering questions about the
diagnostic process and autism symptom severity. This left 78 participants for the following
analyses. Of the 78 participants who answered questions about intervention practices, 50 had
reported discontinuing at least one EBP, 38 had discontinued at least one Emerging treatment,
and 48 had discontinued at least one Complimentary / Alternative practice. Overall, a total of 48
participants had discontinued some non-EBP (either Emerging or Complimentary / Alternative
practice). Additional details regarding discontinued EBPs are presented in Table 10. Details
regarding discontinued non-EBPs are presented in Table 11.
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Table 10. Discontinued EBPs (Total N = 78)
Intervention
Evidence-based practice (EBP)
ABA-Based Behavior Therapy
Cognitive Behavioral Therapy
Modeling
Pivotal Response Training
EIBI
Language Production
Parent Training
Peer Training
Visual Schedules
Scripting
Self Management Training
Social Skills Package
Speech Therapy
Social Stories

n

Percent

22
7
4
2
19
3
2
1
6
1
1
3
22
9

28.21
8.97
7.84
2.56
24.36
3.85
2.56
1.28
7.69
1.28
1.28
3.85
28.21
11.54

Table 11. Discontinued non-EBPs (Total N = 78)
Intervention
n
Emerging (Non-EBP)
Functional Communication
3
Exercise
3
Massage Therapy
2
Music Therapy
8
Occupational Therapy
16
Physical Therapy
7
Picture Exchange (PECS)
3
Sign Instruction
3
Structured Teaching
1
Complimentary/Alternative (Non-EBP)
Acupuncture
0
Animal-Based
4
Art Therapy
1
Sensory Integration
7
Osteopathy
4
Facilitated Communication
0
Floor Time
5
Oxytocin
1
Play Therapy
5
Special Diet
12
Vitamins
8
Chelation
3
Hyperbaric Chamber
2
Packing / Holding
0
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Percent
3.85
3.85
2.56
10.26
21.51
8.97
3.85
3.85
1.28
0.00
7.84
1.28
8.97
7.84
0.00
6.41
1.28
6.41
15.38
10.26
3.85
2.56
0.00

Caregivers endorsed a variety of reasons for quitting previously tried interventions. The
78 participants reporting on intervention history endorsed a range of 0-5 (M = 1.04; SD = 1.22)
of 10 possible barriers resulting in discontinuation of EBPs. Of the 50 participants who reported
having discontinued at least one EBP, the most commonly cited reasons for discontinuation were
changes in eligibility (most commonly cited for EIBI), out of pocket expense, and “other.” The
“other” category provided an option for caregivers to explain the reasons for discontinuation.
Write-in answers included a variety of reasons such as moving to a new geographic location,
changing schools, or caregiver separation/divorce. Of note, analysis excludes those who reported
in the “other” column that they had discontinued services for a non-barrier related reason (e.g.,
the intervention improved symptoms such that the intervention was no longer needed). Table 12
provides additional details about reasons for quitting EBPs.
Table 12. Reasons for quitting past EBPs (N = 78)
Barrier
Percent
n
Not Working
8
10.26
Expense
14
17.95
Eligibility (total)
18
23.08
Eligibility (excluding EIBI) 7
8.97
Insurance change
2
2.56
Scheduling
4
5.13
Provider relationship
7
8.97
Did not like in home
1
1.28
Proximity
2
2.56
Challenging behaviors
2
2.56
Other barrier
13
16.67
Similar to EBPs, the 48 caregivers who reported discontinuation of a non-EBP endorsed a
variety of reasons for discontinuation. Of the reasons for discontinuing non-EBP interventions,
most commonly cited were treatment was not working, out of pocket expense too great, and
“other.” Reasons listed as “other” included child losing interest, providers quitting or moving to
a different location, or family relocating. The 78 participants reporting on intervention history
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endorsed a range of 0-6 (M = 1.24; SD = 1.48) of 10 possible perceived barriers resulting in
discontinuation of non-EBPs. Additional detail is provided in Table 13.
Table 13. Reasons for Quitting Past Non-EBP (N = 78)
Barrier
Percent
n
Not Working
24
30.77
Expense
17
21.79
Eligibility
10
12.82
Insurance change
2
2.56
Scheduling
6
7.69
Provider relationship
3
3.85
Did not like in home
0
0.00
Proximity
2
2.56
Challenging behaviors
5
6.41
Other
14
17.95
Factors Predicting Barriers to EBPs
Multiple regression was used to investigate factors related to experiencing greater
numbers of perceived barriers to diagnostic services. Investigated factors included geography
(living in urban, suburban, or rural areas), family income, ethnicity (minority or not), caregiver
education level, and ASD-DC Total Score. Because individuals who have experienced a longer
period of time between diagnosis and present have had greater opportunity to seek, begin, and
discontinue treatment, this time span was included in the regression as a covariate. Subsequently,
all variables of predictive interest were entered simultaneously. As previously noted, 20 of the
ASD-DC scores were for individuals outside of the designed age range (2-16 years). To account
for this, the analysis was run both with and without these individuals included. Results of both
analyses are reported below.
All participants included. For this participant sample of N = 78, linearity was demonstrated by
partial regression plots and a plot of studentized residuals against the predicted values. There was
independence of residuals, as assessed by a Durbin-Watson statistic of 1.85. The assumption of
homoscedasticity was met, as assessed by visual inspection of a plot of studentized residuals
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versus unstandardized predicted values. There was no evidence of multicollinearity, as assessed
by tolerance values greater than 0.1. Inspection of residuals revealed one studentized deleted
residual greater than ±3 standard deviations for an individual reporting 5 of 8 possible barriers to
diagnosis (studentized residual = 3.53), but inspection of the data point indicated no probable
error in data entry or other reason for removal, and leverage value of 0.08 was within the
acceptable range so this data point was maintained. In one case, a leverage value greater than 0.2
was found; levels of 0.2 to 0.5 are considered “risky,” and values of 0.5 are considered
unacceptable (Cook & Weisberg, 1982; Laerd, 2015). The leverage value of .26 indicated a need
to look more closely at the possibility of undue influence on results. Inspection of Cook’s
distance values indicated no values greater than 1 (range was 0.00 to 0.14), thus all participants
were retained. The assumption of normality was met, as assessed by P-P Plot. The first model,
accounting for time elapsed since diagnosis, did not predict number of barriers causing
discontinuation of EBP, R2 = 0.02, F(1, 76) = 1.34, p = .251, adjusted R2 = 0.004. The addition of
ethnicity, geography, income, ASD-DC score, and education did not lead to a statistically
significant increase in R2, which increased by 0.06. The full model of time elapsed since
diagnosis, caregiver education level, autism symptom severity, family income, caregiver
ethnicity, and geography did not predict number of perceived barriers causing discontinuation of
EBP in a statistically significant way, R2 = 0.07, F(5, 71) = 0.82, p = .478, adjusted R2 = -0.01.
Regression coefficients and standard errors can be found in Table 12 (below). Correlation
coefficients within the context of the regression analysis can be found in Table 13 (below). Of
note, inspection of correlation matrix independent of regression analysis revealed a significant
correlation between barriers to EBP and income (r = -.21, p = 0.31). Regression coefficients and
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standard errors can be found in Table 14. Correlation coefficients within the context of the
regression analysis can be found in Table 15.
Table 14. Hierarchical Multiple Regression Predicting Number of Barriers Resulting in
Discontinuation of EBPs (N = 78)
Model 1 (Covariate)
Model 2
Variable
β
β
B
SEB
B
SEB
Constant
0.86
0.21
0.44
1.16
Months since diagnosis
0.01
0.01
0.13
0.01
0.01
0.17
Geography
-0.02
0.05
-0.05
Income
0.12
0.09
0.18
Ethnicity
-0.22
0.40
-0.07
Education
0.05
0.10
0.06
ASD-DC Total Score
-0.01
0.01
-0.03
2
R
0.02
0.07
1.34
0.93
F
Δ R2
0.02
0.06
ΔF
1.34
0.52
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β =
standardized coefficient
Table 15. Correlation Coefficients of Multiple Regression: Barriers to EBPs (N = 78)
Variable
partial
semipartial p
r
Model 1
Months since diagnosis
0.13
0.13
0.13
0.251
Model 2
Months since diagnosis
0.13
0.16
0.15
0.182
Geography
0.02
-0.05
-0.05
0.656
Income
0.21
0.15
0.15
0.204
Ethnicity
-0.20
-0.07
-0.06
0.577
Education
0.15
0.06
0.05
0.639
ASD-DC Total Score
-0.03
-0.03
-0.03
0.784
Excluding participants outside the ASD-DC age range. This regression analysis excluded data
from participants whose children with ASD were outside of the ASD-DC age range (2-16 years)
at the time of survey completion. This left a total of 60 participants for the following analysis,
which is slightly lower than the sample size recommended via a-priori G*Power analysis. In
analyzing that necessary assumptions were met, linearity was present as assessed by partial
regression plots and a plot of studentized residuals against the predicted values. The assumption
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of homoscedasticity was met as assessed by visual inspection of a plot of studentized residuals
versus unstandardized predicted values. There was no evidence of multicollinearity, as all
tolerance levels were greater than 0.1. There was one studentized deleted residual greater than ±3
standard deviations for an individual reporting 5 of 8 possible barriers to diagnosis (studentized
residual = 3.44), but inspection of the data point indicated no probable error in data entry or other
reason for removal, and leverage value of 0.139 was within the acceptable range so this data
point was maintained. There were seven instances of leverage values greater than 0.2; as noted
above, levels of 0.2 to 0.5 are considered “risky” and values of 0.5 are considered unacceptable
(Cook & Weisberg, 1982; Laerd, 2015). The leverage values ranging from 0.21 to 0.26 indicated
a need to look more closely at the possibility of undue influence on results using Cook’s
distance. Inspection of Cook’s distance values indicated no values greater than 1 (range was 0.00
to 0.22), thus all participants were maintained. The assumption of normality was met, as assessed
by P-P Plot. The first model, accounting for time elapsed since diagnosis, did not predict number
of barriers causing discontinuation of EBP, R2 = 0.05, F(1, 58) = 2.82, p = .098, adjusted R2 =
0.03. The addition of ethnicity, geography, income, ASD-DC score, and education did not lead to
a statistically significant increase in R2, which increased by 0.123. The full model of time elapsed
since diagnosis, caregiver education level, autism symptom severity, family income, caregiver
ethnicity, and geography did not predict number of barriers causing discontinuation of EBP in a
statistically significant way, R2 = 0.17, F (6,53) = 1.79, p = 0.118, adjusted R2 = 0.08; however,
income was significantly correlated with barriers to EBP (r = 0.35, p = .040). Regression
coefficients and standard errors can be found in Table 16. Correlation coefficients within the
context of the regression analysis can be found in Table 17.
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Table 16. Hierarchical Multiple Regression Predicting Number of Barriers Resulting in
Discontinuation of EBPs (N = 60)
Model 1 (Covariate)
Model 2
Variable
β
β
B
SEB
B
SEB
Constant
0.68
0.27
0.43
1.33
Months since diagnosis
0.01
0.01
0.22
0.01
0.01
0.21
Geography
-0.03
-0.06
-0.45
Income
0.25
0.12
0.34
Ethnicity
-0.10
0.46
-0.03
Education
-0.02
0.13
-0.03
ASD-DC Total Score
-0.01
0.01
-0.08
R2
0.05
0.17
2.82
1.79
F
Δ R2
0.05
0.12
ΔF
2.82
1.56
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β =
standardized coefficient
Table 17. Correlation Coefficients of Multiple Regression: Barriers to EBPs (N = 60)
Variable
partial
semipartial p
r
Model 1
Months since diagnosis
0.22
0.22
0.22
0.098
Model 2
Months since diagnosis
0.22
0.21
0.20
0.120
Geography
-0.02
-0.06
-0.06
-0.660
Income
0.35
0.28
0.26
0.040*
Ethnicity
-0.20
-0.03
-0.03
0.828
Education
0.18
-0.02
-0.02
0.863
ASD-DC Total Score
0.01
-0.02
-0.02
0.564
The direction of the correlation between income and perceived number of treatment
barriers indicated that higher income was related to increased difficulty maintaining EBP
services. As insurance is closely related to the out of pocket costs of treatment, follow-up testing
was conducted to investigate the relationship between insurance type and number of perceived
EBP barriers reported. Due to non-normal distribution of data (thus violating assumptions for
one-way ANOVA), a Kruskal-Wallis H test was run to determine if there were differences in
number of barriers reported among three groups based on insurance type: public only, private
only, or both public and private. Distributions of total number of perceived EBP barriers were
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not similar for all groups, as assessed by visual inspection of a boxplot. The distributions of
scores were not statistically significant among groups, χ2(2) = 3.46, p = .178. Participants were
classified into three groups: private insurance only (n = 29), public insurance only (n = 26), and
having both private and public insurance (n = 22). Information on number of barriers reported
per group is presented in Table 18.
Table 18. Perceived Number Barriers Causing Discontinuation of EBP x Insurance Type
Group
Mean(SD)
Range
N
Public Insurance
26
0.69 (0.88)
0-5
Private Insurance
29
1.28 (1.56)
0-3
Both Types Insurance 22
1.14 (1.04)
0-3
SD = Standard Deviation
Predictors of Time Between ASD Diagnosis and First ASD Symptom Treatment
Multiple regression was utilized to investigate the relationship between various
demographic factors of interest (geography, caregiver education, family income, ethnicity, and
ASD-DC total score) and the time between formal ASD diagnosis and receipt of services
targeting ASD symptoms. As previously noted, 24 participants reported their child had begun
receiving treatment for ASD symptoms prior to receiving a formal ASD diagnosis. Additional
information about the types of treatment or how these individuals came to receive the prediagnostic services is not available. Twelve individuals reported beginning treatment within one
month of receiving diagnosis. Of those who have experienced a delay between diagnosis and
treatment, time delay ranged from one month to 31 months. (M = 5.42; SD = 7.36).
Overall, caregivers reported a mean of -0.51 (SD = 13.83) months from diagnosis to
treatment, indicating a slight tendency to receive therapeutic services of some type prior to
receiving formal diagnosis. It is possible that some were enrolled in state-funded early
intervention programs due to conditions often seen early in development for individuals later
diagnosed with ASD, including delayed speech or other milestones. Factors investigated
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included geography (rural, suburban, or urban), child ethnicity, caregiver level of education,
family income, and ASD symptoms severity as reported via the ASD-DC. As with previous
regression analyses, multiple regression to investigate these relationships was conducted first
with all participants and then excluding those participants whose children were outside of the
ASD-DC age range. Results were not significantly different.
All Participants Included
Four of the 88 participants were excluded from this analysis because they reported their
children have not yet begun receiving ASD interventions. A total of 84 participants remained for
this analysis. There was independence of residuals, as assessed by a Durbin-Watson statistic of
2.1. There was linearity as assessed by partial regression plots and a plot of studentized residuals
against the predicted values. There was homoscedasticity, as assessed by visual inspection of a
plot of studentized residuals versus unstandardized predicted values. There was no evidence of
multicollinearity, as assessed by tolerance values greater than 0.1. Inspection of casewise
diagnostics revealed two cases with studentized residuals greater than 3 (SR = -8.50 and -4.47,
respectively). In each of these cases, caregivers reported having accessed treatment for ASD
symptoms many months prior to receiving a formal ASD diagnosis (112 months and 168
months, respectively). Further inspection revealed neither of these points had leverage values
greater than 0.2, nor did they have Cook’s distance values greater than 1. Accordingly, these two
cases were retained for the following analysis. A cubed root transformation was applied to the
data due to observed deviations from normality upon inspection of P-P histogram.
The multiple regression model did not predict time between diagnosis and first treatment
for ASD symptoms in a statistically significant way, F(5, 78) = 1.55, p = .183. R2 for the overall
model was 9.1% with an adjusted R2 of 0.03%, a negligible effect size according to Cohen
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(1988). Overall, the model did not predict time from diagnosis to treatment in a statistically
significant way, though ethnicity did contribute significantly to the model (r = .22, p = .046).
Regression coefficients, correlations, and standard errors can be found in Tables 19 and 20.
Table 19. Summary of Multiple Regression Analysis: Diagnosis to Treatment Time (N = 84)
Variable
β
B
SEB
Intercept
-1.20
1.72
Geography
0.01
0.07
0.01
Income
0.27
0.14
0.25
Ethnicity
1.26
0.62
0.23
Education
-0.15
0.16
-0.13
ASD-DC Total Score 0.01
0.01
0.05
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β =
standardized coefficient
Table 20. Correlation Coefficients of Multiple Regression: Diagnosis to Treatment Time (N =
84)
Variable
partial
semipartial p
r
Geography
-0.05
-0.01
0.01
0.962
Income
0.16
0.21
0.21
0.065
Ethnicity
0.22
0.22
0.22
0.046*
Education
-0.12
-0.11
-0.11
0.337
ASD-DC Total
-0.03
-0.03
-0.05
0.649
Score
Excluding Participants Outside the ASD-DC Age Range
Sixty-three participants remained after excluding those whose children were outside of
the ASD-DC age range at time of survey completion. Of note this is slightly below the sample
size recommended by G*Power (Faul, Erdfelder, Lang, & Buchner, 2007)). There was linearity
as assessed by partial regression plots and a plot of studentized residuals against the predicted
values. There was homoscedasticity, as assessed by visual inspection of a plot of studentized
residuals versus unstandardized predicted values. There was no evidence of multicollinearity, as
assessed by tolerance values greater than 0.1. Inspection of casewise diagnostics revealed no
problematic outliers. Leverage values and Cook’s distance were all within acceptable limits. The
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cubed root transformation used in the previous analysis was similarly applied to this analysis due
to observed deviations from normality upon inspection of P-P histogram.
The multiple regression model did not predict time between diagnosis and first treatment
for ASD symptoms in a statistically significant way, F(5, 57) = 0.96, p = .449. R2 for the overall
model was 7.8% with an adjusted R2 of -0.01%, a negligible effect size according to Cohen
(1988). Overall, the model did not predict time from diagnosis to treatment in a statistically
significant way, all predictor variables p > .05 Regression coefficients, correlations, and standard
errors can be found in Tables 21 and 22 (below).
Table 21. Summary of Multiple Regression Analysis: Diagnosis to Treatment Time (N = 63)
Variable
β
B
SEB
Intercept
-0.01
1.81
Geography
-0.28
0.08
-0.05
Income
0.10
0.16
0.10
Ethnicity
1.17
0.66
0.24
Education
-0.01
0.19
-0.01
ASD-DC Total Score -0.01
0.02
-0.02
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β =
standardized coefficient
Table 22. Correlation Coefficients of Multiple Regression: Diagnosis to Treatment Time (N =
63)
Variable
partial
semipartial p
r
Geography
-0.10
-0.05
-0.04
.728
Income
0.08
0.08
0.08
.542
Ethnicity
0.26
0.23
0.23
.080
Education
0.00
-0.01
-0.01
.947
ASD-DC Total
-.11
-0.02
-0.22
.862
Score
Currently Desired Interventions
Participants were asked about treatments that they would like to try in the future. A total
of 51 participants stated they were seeking additional services. Of those, 41 of the answers could
be clearly categorized into EBP or non-EBP interventions. Twenty-seven desired EBPs; 14
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desired non-EBP interventions. Twenty-one participants indicated they were not interested in
additional services at this time and were thus excluded from these analyses.
Descriptive Analysis
Interventions most frequently desired were related to ABA-based therapy (n = 11), social
skills (n = 8), services from a psychologist specially trained in ASD and/or CBT (n = 5), and
speech therapy (n = 5). A wide variety of both EBPs and non-EBPs were desired, including
hippotherapy (horseback riding used as a therapeutic intervention), off-label medication, help
with transitioning to adulthood or learning job skills, peer modeling, floor time, sensory
integration therapy, art or music therapy, dietary changes, pivotal response training, massage,
acupuncture, osteopathy, academic tutoring, and programs that incorporated typically developing
peers.
The most frequently cited barriers to desired future interventions were expense,
scheduling / time required, and “other,” closely followed by waitlist and proximity (too far) or
other transportation issues. Of caregivers seeking additional interventions, a range of 1-5
barriers (M = 2.02; SD = 1.17) was reported. Participants were also asked to rank the perceived
barriers in order of difficulty each posed, with 1 indicating “most problematic.” Information
about perceived barriers to the desired services is provided in Table 23.
Table 23. Perceived Barriers to Desired Interventions (N = 51)
Barrier
N (%)
Ranked #1 (N%)
Cost
26 (50.98)
15 (29.41)
Scheduling or time required
18 (35.29)
5 (9.80)
Other
17 (33.33)
10 (19.61)
Proximity or transport
15 (29.41)
8 (15.68)
Wait list
15 (29.41)
5 (9.80)
Process to access
10 (19.61)
3 (5.89)
Problem Behaviors
5 (9.80)
2 (3.92)
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Regarding the rank of how problematic the above barriers were perceived, cost was
perceived as the number one barrier for 15 of the participants (29.41%). Ten participants
(19.61%) perceived “other” barriers as most problematic based on rank ordering, and
distance/transportation was most problematic for 8 participants (15.69%). The “other” responses
of some caregivers indicated significant frustration. For example, responses included “Have you
ever tried to get the school to provide something?!” and “So many treatments without proof- so
much Snake Oil. Where to turn?”
Predictors of Desiring EBP Over Non-EBP
A binomial regression was utilized to inspect factors related to whether a participant who
desired additional services was seeking EBP vs non-EBP treatments. Of the 51 participants who
indicated a desire for additional services, 41 answers were able to be categorized into EBP (n =
27) or non-EBP (n = 14) approaches. (The remaining 10 responses were not evident, and
included comments such as “more of what she’s already getting” or “tutoring by someone trained
in ASD”). Due to smaller sample size (Laerd, 2015a), predictive variables were limited to
education, income, and ethnicity. Income and ethnicity were chosen due to evidence of
correlation with past treatment experience in previous analyses; education level was retained
based on previous studies indicating that parental education affected treatment choices, with
higher education corresponding with increased used of non-EBPs (e.g., Salomone and
colleagues, 2015).
Linearity of the continuous variables with respect to the logit of the dependent variable
was assessed via the Box-Tidwell (1962) procedure. A Bonferroni correction was applied using
all eight terms in the model resulting in statistical significance being accepted when p < .00625
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(Tabachnick & Fidell, 2007). Based on this assessment, all continuous independent variables
were linearly related to the logit of the dependent variable. There were no observed outliers.
A binomial logistic regression was performed to ascertain the effects of years of
caregiver education, income, and ethnicity on the likelihood that they were seeking additional
EBP rather than non-EBP. The logistic regression model was not statistically significant, χ2(3) =
9.512, p = .301. The model explained 2.6% (Nagelkerke R2) of the variance in treatment choice
and correctly classified 65.9% of cases. None of the predictor variables were statistically
significant. Additional details are presented in Table 24.
Table 24. Logistic Regression Predicting Likelihood of Seeking EBP at Present Based on
Minority Status, Education, and Income
Wald df p
Odds
95% CI for Odds Ratio
B
SE
Ratio Lower Upper
Minority
-0.75
0.90 0.71
1 .401 0.47
0.08
2.27
Education -0.02
0.24 0.01
1 .983 0.98
0.62
1.56
Income
-0.01
0.20 0.00
1 .995 1.0
0.67
1.46
Constant
1.376
1.58 0.76
1 .617 3.96
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CHAPTER 10: DISCUSSION
Limitations
There are a few notable limitations to this study. Non-Latino white individuals and
higher-SES individuals were over-represented in this sample compared to the United States
averages. Caregivers were self-identified and self-reported their child’s ASD diagnosis;
diagnoses were not independently verified. A larger and more demographically representative
sample would have been desirable. There was a 42% dropout rate for the survey. Nonetheless,
the dropout rate is in line with other online surveys of similar length without compensation
(Galesic, 2006). Additionally, results of this study are in line with previous research indicating
families experience a wide range of barrier types, and some groups (e.g., minority ethnic groups)
are more likely to experience multiple barriers.
Descriptive Analyses
Overall, the study sample accurately represented the higher prevalence of ASD in males
than females. It has been estimated that ASD occurs approximately 4:1 male to female ratio
(Bertaglio & Hendren, 2009); in this sample, 77% male and 23% female distribution closely
mirrors what we would expect in the general population. The sample was not so closely
representative of the United States’ ethnic makeup. In the 2010 United States Census,
approximately 33% of the U.S. population reported their ethnicity as something other than nonLatino white alone, thus qualifying as being of minority ethnic identification (United States
Census Bureau, 2010a). In this sample, minorities were slightly under-represented. Based on the
US Census data, a representative sample would be comprised of approximately 66% white, nonLatino caregivers, but in actuality the sample included approximately 85% white, non-Latino
caregivers. There were slightly fewer white children with ASD (79.5%). For the purpose of
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analysis, ethnicity of the caregiver was used, as this was a study of the caregivers’ experiences.
Families on the higher end of the SES spectrum were also over-represented with a full 34% of
the sample having achieved at least some graduate school education. Only 8% of the sample had
no more education beyond high school. Given a roughly 20% high school dropout rate in this
country (some of whom later go on to receive General Education Development / GED degrees;
Stetser & Stillwell, 2014), a representative sample would include more individuals with high
school or less education than the achieved sample. Although the education and income variables
were not overly correlated, families with higher income were also over-represented. In 2014, the
median household income in the United States was $53,657 (DeNavas-Walt & Proctor, 2015); in
this study sample, only 36% reported family incomes of $55,000 or less. The over-representation
of highly educated, financially well-resourced families may be related to the study being shared
on a listserv for medical doctors who have children with special needs. The rural population was
also somewhat underrepresented. According to the 2010 United States Census (United States
Census Bureau, 2010b), 19.3% of the population resides in rural areas; in this sample, 9.09%
reported living in a rural area.
In this sample, the range of age at first diagnosis varied widely; some variation is
expected as there were several children with reported diagnosis of Asperger’s Disorder, which
under the DSM-IV-TR was often not diagnosed until school age (CDC, 2012). The mean age of
diagnosis was 4.7 years (SD = 3.87 years). In general, recent studies of age at diagnosis have
found that although ASD can sometimes be reliably diagnosed at age 2 years or younger
(Council on Children with Disabilities, 2006; Kim & Lord, 2012), the median age is somewhere
from 4-6 years depending on symptom severity (CDC, 2012; Chakrabarti, 2009; Shattuck et al.,
2009, Yeargin-Allsopp et al., 2003). The children in this sample may have been diagnosed
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slightly earlier on average than expected, but the widely varying ages are representative of the
wide ranges reported in the aforementioned studies.
Fifty-four of the participants in this study reported a gap between diagnosis and
treatment. Of those individuals who did experience a gap from diagnosis to treatment, the mean
wait time was 5.42 months (SD = 7.36 months). The fact that 24 caregivers reported their child
began receiving services for ASD symptoms prior to receipt of a formal diagnosis was
unexpected. It is possible that these children benefitted from state-wide early intervention
services. While each state has their own early intervention program for infants and toddlers with
disabilities through the Grants for Infants and Families Program Part C (United States
Department of Education, 2016), different states may have different criteria for receiving
services. Children generally qualify for services by scoring below a certain cutoff on one or more
developmental domains during standardized testing of abilities after referral for evaluation from
a healthcare provider or family member (the cutoff scores or number of domains that must be
lower than expected may vary from state to state). As discussed under the Diagnosis section of
this paper, developmental delays are often evident in children with ASD before they receive an
ASD diagnosis, and thus these children may qualify for services (e.g., speech therapy) prior to a
formal ASD diagnosis.
Perceived Barriers to Diagnostic Services
The majority of participants (n = 75; 85.23%) reported at least one barrier to diagnostic
services, with the majority reporting multiple barriers (M = 1.68; SD = 1.38). Most frequently
reported were long wait lists, reassurances from professional providers, and difficulties with
scheduling (e.g., having to balance work schedules with clinic visits, or juggling other family
responsibilities). The high number (n = 19; 21.59%) who experienced problems with scheduling
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suggests that professionals may consider offering occasional scheduling outside of the typical
9am-5pm workday to accommodate families who have difficulty scheduling. For example,
occasional evening or weekend hours may alleviate some of the difficulty caregivers face in
scheduling diagnostic services. Anecdotally per the authors’ experience, difficulty with childcare
for other children also presents a difficulty; for example, if a parent has another child with
special needs, or has to travel to a clinic, stay on campus during the assessment period, and then
drive back home, the parent may not be able to pick up other children from school or aftercare
programs on time. Flexible scheduling or assisting with figuring out childcare for other children
may be approaches clinicians can take to assist families facing these scheduling difficulties.
Regarding perceived barriers to diagnosis, the author was especially interested in those
factors that might be ameliorated with educational efforts. Specifically, the author was interested
in factors affecting likelihood of experiencing reassurances from professionals or disagreement
among primary caregivers as perceived barriers to diagnostic services. While the most common
barrier was long wait lists (reported by 49 participants at a rate of 55.68% of the sample),
inspection of the most frequently reported perceived barriers to diagnostic services revealed a
surprising number (33, representing 37.5% of the sample) reported reassurances from
professionals as a factor delaying diagnosis. It is perhaps important to note that this represents
perceived reassurances against diagnostic services; it is possible that healthcare professionals did
not intend to send this message. It is also possible that caregivers are counting non-healthcare
professionals in this category since they were not asked to specify from whom they received this
message, although the examples provided in the survey were all healthcare professionals.
Qualitative data (where participants were given the option to type in additional responses)
indicates that ASD symptoms presented in the context of other developmental problems (e.g.,
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Down Syndrome, partial agenesis of the corpus callosum, global developmental delay) may have
been attributed to the comorbid disorders despite parental concerns that “something else” was
going on. For example, one respondent answered “Pediatrician thought symptoms were due to
Down Syndrome.” Similarly, a second respondent stated of their child with partial agenesis of
the corpus callosum that “we were told that because of [her condition] she could not have autism.
We fought for years before someone would finally do research and discovered she can have
both.” Another respondent replied, “We were told the answers to an 8 question screening
indicated possible autism. We were surprised when the doctor suggested that we might want to
change some of our answers. We didn’t change our answers, but it did make us concerned about
our child’s doctor.” Presumably, these parents were able to get a referral for diagnostic services
that ultimately validated their concerns. It was hypothesized that a binomial regression to inspect
factors predicting this experience would show that an increase in ASD symptom severity (as
measured by the ASD-DC) would correspond with a decreased likelihood of perceiving
professional reassurances as a barrier to diagnosis. It was also hypothesized that increased
education of parents would also correspond with a decrease in perceiving this barrier, as more
educated parents may be better able to engage in good-quality research prior to appointments and
thus may be able to speak more precisely about their child’s symptoms and ask more pointed
questions about autism-specific concerns. However, while ASD-DC total score and caregiver
educational attainment were closer to statistical significance than the other variables (at p = 2.89
and p = .259 respectively), these values are still far from statistical or clinical significance. In the
context of the available information, there were no statistically significant predictors of
perceiving professional reassurances as a barrier to diagnostic services.
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On at least two occasions, parental stressors or comorbidities interfered with pursuit of
diagnostic services. One participant who reported lack of insurance as a barrier added “in
fairness, I did not attempt to get insurance coverage… I have ADHD, I was exhausted and
disorganized.” Another participant (who was not a biological parent) reported that the child’s
parents were too wrapped up in drug addiction to pursue appropriate medical care at the time
despite concerns from others. Regarding familial factors, the author was more specifically
interested in disagreement among caregivers about whether or not to pursue diagnostic services
as a perceived barrier. With 14 (15.91%) of the participants reporting this as a barrier, family
disagreement was the 4th most common barrier reported, after waitlist (55.68%), professional
reassurances (37.50%), and cost (17.05%). Based on literature review (see the section on
Community and Cultural factors) revealing widely varying cultural beliefs about autism causes
and the stigma associated with the disorder, it was hypothesized that ethnicity would impact
likelihood of perceiving caregiver disagreement as a barrier. In actuality, results of the chi-square
test did not indicate a statistically significant increase in experiencing this barrier for participants
who identify as ethnic minorities. This result should be interpreted cautiously, as non-white
participants were under-represented in this sample, and relatively few (15.91%) endorsed this
barrier. Additional research into this topic would benefit from larger sample sizes that contain a
greater number of individuals endorsing this perceived barrier.
The author was also interested in factors that predict greater likelihood of experiencing
multiple barriers to diagnosis. Multiple regression was used to investigate ethnicity, geographical
location, household income, caregiver educational attainment, and ASD symptom severity based
on ASD-DC Total Score as predictive factors for experiencing increased numbers of perceived
barriers. It was hypothesized that living in an urban area, higher household income, higher
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educational attainment, and greater ASD symptom severity would be correlated with fewer
reported barriers to diagnostic services, whereas identifying as an ethnic minority would be
correlated with an increase in barriers, perhaps in part due to a correlation in this country
between minority status and greater barriers to achieving higher education and income. In this
sample, ethnicity was not overly correlated with any of the predictive variables, thus avoiding the
problem multicollinearity in the analysis. The analysis was run both with and without the
individuals who were technically outside of the age range for which the ASD-DC was designed.
Overall, the model did not show statistical significance in predicting the number of barriers
experienced in pursuit of diagnostic services in either case. Interestingly, in the smaller sample
that excluded those outside the ASD-DC age range, ethnicity was significantly correlated with
the outcome variable (number of perceived barriers reported) independent of the model. One
must be cautious of reading too much into this result as the descriptive correlations provided do
not account for multiple comparisons in the same way that running the full analysis does, and
minorities were somewhat under-represented in this sample as previously discussed. However,
this area may be worthy of additional research in the future with a larger sample size in which
individuals who identify as ethnic minorities are better represented.
Perceived Barriers Causing Discontinuation of Past Interventions
Descriptive analyses of information related to discontinued past interventions revealed
that the most frequently discontinued EBPs were ABA-based behavior therapy and speech
therapy (n = 22; 28.21% for each), followed by EIBI (n = 19; 24.36%). Of note, 11 of the
individuals who quit EIBI reported the service was discontinued due to changes in eligibility;
this is unsurprising as many of the state-funded early intervention programs or other
regional/local programs that help fund EIBI have age cutoffs of 3 or 5 years (and indeed, the
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very title Early Intensive Behavior Intervention indicates it is a treatment for use during early
childhood). Due to the way the survey was streamlined based on feedback from dissertation
committees and pilot participants, it is impossible to determine what was the most common
cause for discontinuation of ABA-based therapy. It is surprising that only 2 participants (2.56%)
endorsed distance/proximity to treatment as a major barrier leading to discontinuation of past
EBP interventions; it may be that individuals take this into account before beginning treatments
and are unlikely to begin interventions at all if they perceive distance as too great. On the other
hand, perhaps EBP service provision is improving in less populated areas. On the whole, the
most frequently reported reasons for discontinuing EBPs were eligibility, expense, and “other.”
Excluding EIBI, top-ranked reasons for quitting EBPs were expense, “other,” and “not working.”
The “other” category offered the option for caregivers to elaborate on their answers, and several
indicated frustration with quality of services provided. For example, one individual stated “the
county-sponsored stuff was nearly worthless… and private stuff was hugely expensive.” Another
stated “services were poor quality.” Other barriers reported in the “other” category included
“facility closed,” “only helpful if it’s a whole bunch of it, but nobody here provides that,”
“therapists all geared towards younger patients,” “therapist took a break,” “therapist left now we
are back on a wait list,” and “unable to find new service providers when old ones quit.” Seven
individuals (8.97%) reported having discontinued an EBP due to poor relationship with the
provider, and one due to disliking having services provided in the home. It is discouraging that
many individuals discontinued EBPs due to difficulties with provider relationships or due to
discontinuation of services due to therapists leaving or facilities closing. Certainly, service
providers should engage in internal quality assessment to ascertain the fidelity of the provided
services; an EBP is no longer evidence-based if it is not accurately administered. Service
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providers should also work to ameliorate any difficulties that may arise in the relationship with
the caregivers when possible. It may be that the caregivers who discontinued due to problems
with providers never raised their concerns to the providers, thus providers may not have had an
opportunity to work to rectify the problems. Periodically checking in regarding caregiver
satisfaction with services provided may be a way to address this concern without taking much
time, as in periodically asking parents to complete a brief satisfaction questionnaire. It is
encouraging that far fewer individuals discontinued EBP due to the practice not working (n = 8;
10.26%) compared to the 24 participants (30.77%) who discontinued non-EBPs for the same
reason. Overall, it was hypothesized that cost would be more frequently reported as a barrier to
non-EBP over EBP because insurance is far more likely to reimburse for EBP. While the
hypothesized result was true with 17.95% reporting cost as a barrier to EBP and 21.79%
reporting cost as a barrier to non-EBP, overall out-of-pocket cost was one of the top barriers for
both types of interventions.
The most frequently discontinued non-EBPs included occupational therapy (n = 16;
21.51%), special diets such as gluten or casein-free (n = 12; 15.38%), vitamins (n = 8; 10.26%),
and sensory integration therapy (n = 7, 8.97%). The top reported reasons for quitting non-EBPs
included “not working,” expense (n = 17; 21.79%), and “other” (n = 14; 17.95%). As with EBPs,
a variety of reasons for discontinuation were reported in the “other” category. Examples include
death of providing practitioner, “therapist had no clue,” “therapy became unavailable,” and
“therapist feeling he didn’t respond.” Of note, three participants endorsed having used chelation
therapy and two reported having used hyperbaric chamber therapy in an attempt to treat ASD
symptoms (one participant endorsed both). It is unsurprising that three of the four participants
who had tried one of these interventions reported discontinuation because the practices were not
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working. (The participant who tried both was apparently undeterred by inefficacy, but
discontinued due to out of pocket cost being too expensive). There is not only substantial
research to support the ineffectiveness of these approaches, but also that these practices present
considerable risk of substantial harm. It is on the one hand fortunate that only four participants
(5.13%) of the 78 in this analysis endorsed having tried these dangerous and sometimes invasive
techniques; on the other hand, it is troubling that any health care provider would provide these
interventions without clear medical indication. The author wonders where participants
encountered spurious claims of efficacy for these dangerous practices; despite the comparatively
low number of caregivers pursuing hyperbaric chamber or chelation therapies, future research
into which caregivers are likely to pursue dangerous and invasive practices and where they are
getting information and treatment could help inform targeted educational efforts to decrease use
of these ineffective practices in efforts to treat ASD symptoms.
Given that EBPs for ASD are by definition generally effective at improving ASD
symptoms, the author was especially interested in factors predicting experiencing a greater
number of barriers leading to discontinuation of EBPs. Similar to hypothesized results for
barriers to diagnosis, it was hypothesized that lower household income would predict higher
numbers of reported barriers. Financial providers in families with lower income may have lowpaying entry-level jobs; many of these jobs entail hourly wages rather than salary. This can make
it more difficult to take time away from work as any time away entails loss of income. Lowincome families may be more likely to be headed by a single parent, amplifying problems with
scheduling or transportation. It was also hypothesized that rural location would be indicative of
higher number of reported barriers, followed by lower educational attainment as a predictor of
greater perceived barriers. It was hypothesized that higher ASD symptom severity as measured
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by the ASD-DC would be predict fewer barriers as it may be easier to qualify for multiple
services or more comprehensive programs, including programs to provide financial assistance for
healthcare services, when symptoms are more severely impacting functioning. After co-varying
time elapsed since diagnosis, multiple regression investigating geography, family income,
ethnicity, caregiver education level, and ASD-DC total scores as predictors revealed the model
was not effective at predicting increased number of reported barriers to past EBP. As with the
analysis on barriers to diagnostic services, the analysis was run both with and without the
participants who were outside of the age range for which the ASD-DC was designed. The results
were slightly different; in the all-inclusive analysis, income was found to be significantly
correlated with the outcome variable (number of perceived barriers to EBP reported) but it was
not significantly predictive within the context of the model. In the analysis that excluded the 18
participants outside of the ASD-DC age range, income was significantly correlated with higher
rates of reported EBP barriers. In summary, while the models did not significantly predict
number of barriers experienced in continuing EBPs, a surprising trend indicated that families
with higher incomes are more likely to report multiple barriers resulting in discontinuation of
services.
In light of the surprising trend that participants from higher-income families were more
likely to report multiple barriers resulting in discontinuation of EBPs, it was then hypothesized
that insurance may play a role in this finding, with those with public insurance facing fewer
challenges to maintaining services. Thomas and colleagues (2007) found that children covered
by public insurance had much greater odds of using a variety of therapeutic services as well as
medication management than those covered by private insurance; children covered by public
insurance were also less likely to use some complimentary/alternative approaches (e.g.,
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supplements) compared to those covered only by public insurance. These same authors also
found that children without insurance were most likely to receive services that facilitated entry
into the healthcare system. In 2014, Parish and colleagues found that after controlling for
symptom severity and demographic characteristics, families with private insurance were more
than five times as likely to have out of pocket costs for ASD treatments compared to those
children covered by public health insurance. Most frequently, these costs were related to
outpatient services, medications, and dental care. The results found in this study may be because
children from families with lower income are more likely to be covered by Medicaid, which may
cover more ASD treatment services than the average private insurance plan. Accordingly,
families who do not qualify for Medicaid due to higher family income may incur significantly
greater financial burdens for their child’s ASD-related healthcare. Additionally, it is possible that
these middle- or higher-income families would benefit from some of the services (e.g.,
transportation to and from therapy or medical appointments) that are available to individuals who
receive Medicaid.
Inspection of means and standard deviations of number of barriers resulting in
discontinuation of EBPs indicated that on average, individuals with private insurance reported
greater difficulty maintaining EBPs than those with public insurance, which is in line with
previous research. Additionally, individuals who had both public and private insurance reported
more barriers than those with public only, but fewer than those with private only. The results of
the Kruskal-Wallis analysis were not significant; however, it is possible that in this sample there
was a “basement effect” since many individuals (fortunately) reported relatively few barriers to
EBP. It is possible that more nuanced information regarding insurance type and access to
services might shed light on the validity of this trend and reveal significant results consistent
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with results of previously published studies. It is possible that individuals who have both public
and private insurance experience significantly more frustration in accessing services due to
difficulties inherent in having both public and private insurance. In particular, public insurance
(e.g., Medicare) often requires that individuals who have both types of insurance file with their
primary (private) insurance first. However, the private insurance may not cover the desired ASD
treatment. Attempts to resolve this issue and obtain coverage can require appeals and multiple
communications between each insurance provider; even once the process is resolved and public
insurance agrees to cover what the primary/private insurance does not, periodic reauthorization
may be required. As laws surrounding ASD coverage by private insurance continue to change
and more states mandate coverage of at least some EBPs for ASD, continued research into the
effects of insurance coverage on access to services will remain an important area of research.
Predictors of Time Between ASD Diagnosis and First ASD Symptom Treatment
Overall, caregivers reported a slight tendency for their children to begin receiving
treatment prior to receiving formal ASD diagnosis (M = 0.51 months prior to diagnosis; SD =
13.83 months). Particularly in light of the mean age of first diagnosis (M = 4.70 years, SD =
3.87 years), the large standard deviation of time between diagnosis and treatment fits with the
hypothesis that many individuals may have been enrolled in early intervention programs for
children with developmental delays. Unfortunately the contents of the survey do not allow for
verification of this hypothesis. If, however, state early intervention programs are identifying
children at risk for a later diagnosis of ASD, the children would likely be receiving interventions
targeting communication, a core ASD symptom that is often evident early in development.
Engagement with early intervention programs would also be likely to facilitate later diagnostic
assessment for ASD. The large standard deviation also indicates that a considerable number of
84

children experienced a substantial lag between diagnosis and treatment. Results of the regression
model did not predict time between treatment and diagnosis in a statistically significant way.
However, ethnicity was significantly correlated with time between diagnostic and treatment
services; minority caregivers were more likely to report a lag time between diagnosis and
treatment. This is consistent with previous research; for example, Rosenberg and colleagues
(2008) found that black children were only half as likely as their white peers to receive early
intervention services. Zuckerman and colleagues (2014) found that some Latina mothers reported
avoided seeking out treatment services directly following an ASD diagnosis because the
diagnosis was so stressful that families needed time to adjust and cope with the news before
moving on in the process of accessing treatment. Disparities in service access and utilization
indicate a continued need to develop public policies and culturally-sensitive educational and
outreach programs to address the gap in service use.
Currently Desired Interventions
Fortunately, the majority of caregivers seeking additional ASD interventions for their
children were seeking EBPs. Similar to the reported barriers to diagnosis and previously tried
intervention services, cost presented the most frequently cited barrier for desired future
treatments, and was also the most frequently mentioned as “most problematic or challenging”
barrier. This is in line with results from the previous analysis regarding barriers to diagnostic and
previous treatment services. Scheduling or time required was second most frequently ranked,
though “other” barriers were viewed as slightly more problematic. Regarding scheduling, clinicbased providers able to offer evening or weekend hours or a combination of clinic and in-home
services might be well-suited to help address the scheduling difficulties many families face.
“Other” barriers were the third most frequently and second most highly ranked. “Other” barriers
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were highly variable, and included desiring services not provided by the child’s assigned school
system, ineligibility due to age, difficulty getting insurance approval, not knowing where to find
the services or difficulty locating providers, and comorbid medical diagnoses requiring
specialized health care. The wide range of difficulties faced in accessing ASD services highlights
the need for individualized care and, in some cases, assistance with care coordination to help
connect families with other service providers.
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CHAPTER 11: CONCLUSION
ASD is a lifelong neurodevelopmental disorder, but early and accurate diagnosis paired
with developmentally appropriate interventions across the lifespan can significantly improve
long-term outcome and quality of life for individuals with ASD and their families. Many of the
families in this study reported having received some services for ASD symptoms. It is not known
how many of these children were getting services specifically through state-wide early
intervention programs for children with developmental delays, but but it is promising that these
individuals became involved so early on with some type of service provision. It is likely that
being involved with early intervention services makes it easier to follow up and get in touch with
the appropriate diagnostic and additional services as ASD symptoms become more apparent or
problematic as a child ages. Scheduling diagnostic services can be challenging. More than half
of caregivers cited long wait lists as a barrier to diagnostic services, and accessing diagnostic
services can be further complicated by difficulties with scheduling around work, childcare, and
other obligations. Service providers may consider offering occasional scheduling outside of the
typical 9am-5pm workday to accommodate families who have difficulty scheduling during these
times. For example, periodic weekend or evening hours may alleviate some of the difficulty
caregivers face in scheduling diagnostic services.
It was surprising how many caregivers (37.5%) reported having been told by
professionals (e.g., pediatricians) “not to worry” about their child’s difficulties. Caregivers
reported being reassured that their child would grow out of their problems, felt their concerns
were dismissed, or were told that their child could not have autism (e.g., due to presence of
another condition, such as Down Syndrome) and so pursuing diagnostic services was not needed.
Granted, these were perceived reassurances and it is possible that the message the caregivers
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heard was not the intended message on the part of the provider; regardless, these high rates of
misguided professional reassurances perceived as barriers to diagnostic services is disturbing and
more research into this area is warranted to discover whether additional education of healthcare
providers on ASD, consideration of more effective communication techniques with parents, or
both would be beneficial in reducing these rates.
Although sample size and low rates of caregivers identifying as ethnic minorities is a
limitation of this study sample, ethnicity was positively correlated with number of perceived
barriers to diagnosis. Minority caregivers were also more likely to report a lag time between
diagnosis and treatment. Despite substantial strides in addressing ethnic disparities in healthcare
over the past couple of decades, differences still persist. Disparities in services access and
utilization indicate a continued need to develop public policies and culturally-sensitive
educational and outreach programs to address gaps in service use.
The results of this study also highlight the variety of barriers caregivers may face when
pursuing therapeutic services for their child with ASD. In particular, out of pocket expense
remains the most often-reported barrier to accessing and maintaining evidence-based
interventions to treat ASD. Interestingly, those with higher income reported greater number of
barriers to EBPs. This may be in part related to likelihood of higher income families having
private, rather than public, insurance. Insurance type appears to be related to number of
difficulties experienced in treatment and future research in this area is warranted as insurance
policies continue to change their coverage for ASD-related services. In this study, although
statistical significance was not reached, the trend was in line with previous research indicating
that individuals with private insurance tended to report greater difficulties in accessing services
than those with public insurance. Interestingly, those with both public and private insurance fell
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in the middle with regard to number of barriers to evidence based treatments. It is possible that
those who have both types of insurance experience significantly more frustration in accessing
services due to the process of being told to file first with private insurance, even if that insurance
does not cover the service, before applying to Medicaid, and then having to content with periodic
appeals and re-authorization. Each additional required step represents another chance for clients
to fall through the cracks. Additional research into factors related to insurance-related difficulties
is warranted.
Many caregivers reported having discontinued previous EBPs due to difficulties in their
relationship with the provider or the way in which services were rendered. Based on these
results, perhaps service providers should more strongly consider engaging in systematic internal
quality assessment to ascertain the fidelity of the provided services as well as periodically
checking in regarding caregiver satisfaction with the provided services. For example, providers
may consider periodically asking parents to complete a brief satisfaction questionnaire as a way
to scan for areas of dissatisfaction without taking too much time away from clinical services.
Others discontinued because their therapist left or facility closed, which leads one to wonder
what factors prohibited these individuals from continuing the same services with a different
provider.
It was encouraging that only a small number (4 total) in the sample endorsed having tried
any invasive, dangerous non-EBPs in the past. Three of these quit due to the treatments not
working; one discontinued due to expense. On the other hand, it is disturbing that these
participants were able to access chelation and hyperbaric chamber treatments for their children
with no medical indication. Not only are these practices expensive and ineffective at treating
ASD symptoms, but they also carry risk of significant harm. Continuing research into what leads
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caregivers to pursue these treatments and what types of providers are providing these potentially
detrimental services is warranted.
While significant strides have been made in recent years towards improving timely and
affordable access to high quality, evidence-based diagnostic and treatment services, many
caregivers still experience considerable challenges and frustrations when seeking services for
their children. Clinicians, researchers, and public policy advocates should continue to bear these
differences in mind as efforts continue to eliminate disparities in access to care.
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APPENDIX A: SURVEY
Survey for Caregivers of Individuals with Autism Spectrum Disorder
CONSENT TO PARTICIPATE
Thank you for your interest in the “Autism Spectrum Disorders Survey of Experiences,
Interventions, and Resource Availability” research project.
The experience of getting an ASD diagnosis and subsequently obtaining treatment
services varies widely based on many factors, but it is not unusual for caregivers to report
some difficulties obtaining services, or feel overwhelmed at times in the process of
deciding which interventions to pursue.
The purpose of this research is to learn more about the experiences of caregivers of
individuals with Autism Spectrum Disorder (ASD). For this study, we want to hear
from primary caregivers of individuals with ASD. We want to learn more about YOUR
experience navigating the path to diagnosis and treatment for your child. We are
collecting this data to inform efforts to improve this process, making it easier to get
effective services for individuals with ASD.
The procedure involves filling an online survey that will take approximately 15-20
minutes. The survey questions will be about experiences related to assessment and
interventions for Autism Spectrum Disorder.
Your responses will be confidential and combined with the answers of other survey
participants. To protect your privacy, we will not be collecting any information that could
be traced to you individually, and the survey software (Qualtrics) allows us to block IP
addresses from being collected. All data is stored in a password protected electronic
format on a secure server. The results of this study will be used for scholarly purposes
only and may be shared with Louisiana State University representatives.
Your participation in this research study is voluntary. You may choose not to participate
or withdraw from participation at any time during the survey by closing the window.
Most questions will have a “prefer not to answer” or “not applicable” option. There is no
incentive or payment for your participation, but we sincerely appreciate your contribution
towards helping us understand how to improve services for individuals with ASD. If you
wish to withdraw any information collected from the analysis, contact Lindsey Williams
at lwil175@lsu.edu.
This research project being conducted by graduate students in Clinical Psychology at
Louisiana State University. If you have any questions about this research, you can contact
Lindsey Williams at lwil175@lsu.edu .
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This research has been reviewed and approved according to Louisiana State University
Institutional Review Board procedures for research involving human subjects. Questions
about subjects' rights or other concerns can be directed to Robert C. Mathews, Chairman,
Institutional Review Board, (225) 578-8692, irb@lsu.edu, or via www.lsu.edu/irb.
ELECTRONIC CONSENT: Please select your choice below.
Clicking on the "agree" button below indicates that:
• you have read the above information
• you voluntarily agree to participate
• you are at least 18 years of age
If you do not wish to participate in the research study, please decline participation
by clicking on the "disagree" button.
Respondent Demographics
o How did you learn about this survey? (Write in)
o Your relationship to individual with ASD
 Biological mother
 Biological father
 Adoptive mother
 Adoptive father
 Other (Write in)
o Ethnicity
 Caucasian
 Latino
 Middle Eastern
 African American
 Caribbean
 South Asian
 East Asian
 Combination (Write in)
 Other (Write in)
 Prefer not to answer
o Gender
 Identify as male
 Identify as female
 Prefer not to answer
o Highest level of education completed
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Some high school
High school graduate
Technical, associate, or professional degree
Some college
College graduate
Some graduate school
Graduate degree (e.g., Masters or above)
Prefer not to answer

o Annual household income (US$)
 Less than 10,000
 10k-25k
 25k-40k
 40k-55k
 55k-70k
 70k-100k
 More than 100k
 Prefer not to answer
o Current marital status
 Single, never married
 Married or in long-term relationship
 Separated or Divorced
 Widowed
 Other
 Prefer not to answer
o Current state where you currently live (drop down)
Designation of urban, suburban, and rural use the 2010 US Census criteria
o How would you describe your city/town?
 Urban (50,000+ people)
 Suburban (2,500 to 49,000 people)
 Rural (less than 2,500 people)
Child/Adolescent Information
o Age (years, months)
o Ethnicity
 Caucasian
 Latino
 Middle Eastern
 African American
 Caribbean
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South Asian
East Asian
Combination (Write in)
Other (Write in)
Prefer not to answer

o Gender
 Identify as male
 Identify as female
 Prefer not to answer
o Current Autism Spectrum Disorder diagnosis
 Autistic Disorder
 PDD-NOS (Pervasive Developmental Disorder, Not Otherwise
Specified)
 Asperger’s Disorder
 Autism Spectrum Disorder
 Not sure
 Write in: _____
o How old was your child when he or she received the autism diagnosis you
indicated above? (write in __ years and __ months)
Now you will see some questions related to different behaviors.
Rate each item for the extent that it is/was ever a problem. Compare the child
to other children his/her age based on the following:
0 = Not different; no impairment
1 = Somewhat different; mild impairment
2 = Very different; severe impairment

1 Communication skills.
2 Age appropriate self-help and adaptive skills (i.e., able to take care of self).
3 Engages in repetitive motor movements for no reason (e.g., hand waving,
body rocking, head banging, hand flapping).
4 Verbal communication.
5 Prefers foods of a certain texture or smell.
6 Ability to recognize the emotions of others.
7 Maintains eye contact.
8 Social interactions with others his/her age.
9 Response to others' social cues.
10 Use of language in conversations with others.
11 Shares enjoyment, interests, or achievement with others (e.g., parents,
friends, caregivers).
12 Ability to make and keep friends.
13 Interest in participating in social games, sports, and activities.
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14 Interest in another person's side of the conversation (e.g., talks to people
with intention of hearing what others have to say).
15 Able to understand the subtle cues or gestures of others (e.g., sarcasm,
crossing arms to show anger).
16 Use of too few or too many social gestures.
17 Body posture and/or gestures.
18 Communicates effectively (e.g., using words, gestures or sign language).
19 Displays a range of socially appropriate facial expressions.
20 Restricted interests and activities.
21 Eye-to-eye gaze.
22 Reaction to sounds and sights.
23 Walks or runs on toes/balls of feet (If unable to walk/run, rate "0").
24 Reads nonverbal cues (body language) of other people. (If blind, rate "0").
25 Expects others to know their thoughts, experiences, and opinions without
communicating them (e.g. expects others to "read his/her mind").
26 Use of facial expressions.
27 Saying words and phrases repetitively (If nonverbal, rate "0"). ____
28 Make-believe or pretend play. ____
29 Understanding of age appropriate jokes, figures of speech, or sayings. ____
30 Gives subtle cues or gestures when communicating with others (e.g., hinting).
31 Becomes upset if there is a change in routine.
32 Needs reassurance, especially if events don’t go as planned.
33 Language development.
34 Responds to others’ distress.
35 Socializes with other children.
36 Use of nonverbal communication.
Diagnosis
o Which, if any, difficulties did you experience when you were trying to get a
diagnosis? Select all that apply.
 Long wait list (longer than 1 month) for assessment
 Transportation problems (too far to drive or we did not have easy
access to transportation)
 Scheduling problems (e.g., could not get time off of work, or could not
arrange for necessary childcare for other children)
 Insurance would not cover assessment
 Insurance would cover part of assessment but out of pocket cost was
still too high
 Caregivers were unsure or disagreed with one another about whether
to get assessment
 Professionals reassured us that there was no problem or my child
would “grow out of it”
 Other (write in)
o How old was your child when he or she began receiving any treatment for the
autism diagnosis you indicated above? (Write in: ___ years and ___ months)
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o Is your child currently taking prescribed medication meant to address
symptoms related to autism, mood/anxiety, or AttentionDeficit/Hyperactivity Disorder?
 Yes, currently taking medication for autism symptoms (Write in)
 Yes, currently taking medication for mood or anxiety symptoms
(Write in)
 Yes, currently taking medication for Attention-Deficit/Hyperactivity
Disorder (Write in)
 No, not currently taking medication for any of these reasons
o Please indicate which, if any, of the following apply to your child:
 Has received a diagnosis of Intellectual Disability (may be referred to
as mental retardation in older reports)
 Currently exhibits aggressive behavior toward other people (e.g.,
hitting, pinching, biting)
 Currently exhibits self-injurious behavior (e.g., head banging, biting
self, or other methods of injuring him or herself)
 Sleep problems on a regular basis (more nights than not; e.g., takes
more than 30 minutes to go to sleep, wakes up frequently during the
night)
 Has received a diagnosis of seizure disorder or epilepsy
Insurance Information
o What type of insurance coverage does your child have?
 None
 Private Insurance only (e.g., through a parent’s employer)
 Medicaid or other public insurance
 Both private insurance and Medicaid / public insurance
 Not sure or prefer not to answer
o If your child has insurance, does the insurance offer coverage for any autism
treatment?
 Yes, and I am satisfied with the coverage. They provide adequate
coverage for both the types services and the amount of those services
that my child needs.
 Yes, for some things, but I have had difficulty getting them to cover
services, or they don’t provide the types of services I want.
 No
 Not sure
Autism Interventions
o For the next few questions, we will be asking about types of treatments your
child currently receives.
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The lists below is presented in randomized order. The titles in italics
will be the ones used by the researchers for the purposes of
classification/analysis but will not be visible for the participants.
Each list below will be prefaced with: Does your child currently use
any of the following treatments? (yes/no)













List 1 EBP - EIBI
 Early Intensive Behavioral Intervention
List 2 EBP - Behavioral
 Applied Behavior Analysis (ABA)
 Modeling
 Pivotal Response Training
 Natural Teaching Strategies
List 3 EBP – Cognitive Behavioral
 Cognitive Behavioral Intervention Package
 Cognitive Behavioral Therapy
List 4 EBP – Language
 Language Training (Production)
 Speech therapy
List 5 EBP – Non-clinician as Therapist
 Parent Training
 Peer Training Package
 Self-Management Training
 Schedules
List 6 EBP – Social Skills
 Scripting
 Social Skills Package
 Story-Based Intervention (e.g., Social Stories)
List 7 CAM – Social/Communication
 Alternative Communication Devices
 Functional Communication Training
 Picture Exchange Communication System
 Sign Instruction
 Facilitated Communication
 Music Therapy
 Animal-assisted Therapy
 Floor Time
 Play Therapy
List 8 CAM – Mind/Body
 Exercise
 Massage Therapy/Deep Pressure
 Auditory and/or Sensory Integration
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 Chiropractic
 Art Therapy
 Acupuncture
List 9 CAM – Biomedical
 Vitamins and supplements
 Special or restricted diets (e.g., gluten-free, casein-free,
yeast-free)
 Oxytocin
List 10 CAM – 2
 Chelation
 Hyperbaric oxygen therapy (HBOT)
 Packing
List 11 CAM – Other
 Occupational therapy
 Physical therapy
Other (Write in)

Once these questions are completed, the participant will continue to the next page, which
will have an additional question related to each treatment group option endorsed as
currently in use.
o How many hours per week does your child spend receiving and/or using any
of these treatments? (write in)
Autism Intervention Information Sources
o Where do you get information about autism treatments? (Select all that apply.)
 Websites
 Online forum/support group
 Word of mouth from someone who is a caregiver of individual
with ASD
 Word of mouth from someone who is not a caregiver of individual
with ASD
 Doctor (pediatrician or primary care physician)
 Magazines
 Books
 School/classroom teacher
 ABA therapist
 Occupational therapist
 Physical therapist
 Psychologist
 Parent support group that meets in person
 TV
 Newspaper
 Other (Write in)
Once these questions are completed, the participant continues to the next question, which
will only include the information sources endorsed in the previous question as options.
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o Of the sources of information about autism treatments you use, which is your
most trusted source?
Intervention Barriers
o Now you will again see some lists of interventions sometimes used for autism
symptoms. Maybe your child currently uses some of these treatments; perhaps
there are some he/she has never used. We would like to know if within each
list of treatments you see any that your child used to use, but then quit using
for some reason. There are 6 lists; some lists will be different than the lists
you saw previously.
Presentation of the following lists is randomized. Each list is preceded by the instruction
below:
o For the following list please select any treatments your child used to use but
then quit. You can select as many as apply in each list. (If none of these apply,
select “none of the above.”)
 List 1 EBP – Past EBP List 1
 Applied Behavior Analysis (ABA)
 Cognitive Behavioral Intervention Package
 Cognitive Behavioral Therapy
 Modeling
 Pivotal Response Training
 None of the above
 List 2 EBP—Past EIBI (listed separately due to high likelihood of
“aged out of services” listed as reason no longer used)
 Early Intensive Behavioral Intervention
 None of the above
 List 3 EBP – Past EBP List 3
 Language Training (Production)
 Natural Teaching Strategies
 Parent Training
 Peer Training Package
 Schedules
 Scripting
 Self-Management Training
 Social Skills Package
 Speech therapy
 Story-Based Intervention (e.g., Social Stories)
 None of the above
 List 4 non-EBP – Past
 Alternative Communication Devices
 Exercise
 Functional Communication Training
 Massage Therapy/Deep Pressure
 Music Therapy
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 Occupational Therapy
 Physical Therapy
 Picture Exchange Communication System
 Sign Instruction
 Structured Teaching
 None of the above
List 5 CAM – Past
 Acupuncture
 Animal-assisted Therapy
 Art Therapy
 Auditory and/or Sensory Integration
 Chiropractic/osteopathy
 Facilitated Communication
 Floor Time
 Oxytocin
 Play Therapy
 Special or restricted diets (e.g., gluten-free, casein-free,
yeast-free)
 Vitamins and supplements
 None of the above
List 6 non EBP – Dangerous
 Chelation
 Hyperbaric Oxygen Therapy (HBOT)
 Packing / Holding Therapy
 None of the above
List 7
 Other (Write in)
 None of the above

For each list, if any answer other than “this question does not apply,” is selected, a
drop-down box appears.
o You said your child used to use but quit using the intervention(s) you selected
above. Why? Think about the treatment(s) he/she quit using from this list.
Below, select any of the reasons for quitting the intervention(s) you just listed.



Not seeing enough benefit from the treatment
Financial- out of pocket expense too great




My child was no longer eligible due to age or change in diagnosis
Change in insurance coverage



Took too much time or the scheduling was too inconvenient with
other family obligations
Dissatisfied with the relationship with direct care providers (e.g.,
felt they were untrained, unprofessional, or inconsistent)
Did not like having service providers in my home
Proximity to my area- distance was too far to travel
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My child’s behavior interfered with treatment at that time (for
example, aggression, self-injury, refusal to get out of car)
Other (write in)

o Is there any treatment you wish your child were currently receiving? If you
select “yes” you can list up to three.
 No
 Yes
 (Write in)
 (Write in)
 (Write in)
If “yes” is selected above, the next question appears, with a drop down box next to each
option so the participant may select numbers 1-9 or “does not apply”:
o Think about the treatments you wish your child could receive right now.
Which of the following are the most frustrating/problematic right now? Select
as many reasons as you think apply and rank them in order with 1 being the
most frustrating/problematic. (If an option does not apply select “does not
apply”)
 Waitlists are too long
 Distance- I have reliable transportation but the distance is just too
far
 Lack of Transportation- lack of reliable access to a vehicle and/or
driver
 Financial- out of pocket expense too great
 Scheduling is too inconvenient for me / family (e.g., therapy time
interferes with employment or other family obligations)
 My child’s current treatments take so much time that I don’t want
to add another at this time
 I have tried or am trying to access this treatment, but the
enrollment process is confusing/difficult
 My child has challenging behaviors need to be addressed first (e.g.,
is aggressive, destructive, or runs away)
 I just have not gotten around to it yet, no real barriers
 Other (write in)
END OF SURVEY
Thank you for your participation in this study to help us understand more about services for
Autism Spectrum Disorder (ASD). Below we have listed some additional information you may
find to be useful.
I’m looking for treatment for my child. What should I look for?
ASD is a complex disorder that impacts each child differently; no single therapy works equally
for every child. Some therapies are supported by research showing their efficacy, whereas others
are not. The skill, experience, and style of the therapist are critical to the effectiveness of the

112

intervention. Before you choose an intervention, you will need to investigate the claims of each
therapy so that you understand the possible risks and likely benefits for your child.
As noted by the Autism Science Foundation, anyone can start a journal or post a study on the
Internet to make scientific-sounding claims about dangerous or useless interventions. Fringe
treatment providers prey on desperation and fear and deceive parents with numerous unfounded
claims. These fringe treatments are often expensive and cumbersome, consuming time and money
that could be more effectively used elsewhere. Remember there is no cure for ASD, but there are
some treatments that have been reliably shown to help individuals with autism. We call these
evidence-based treatments.
The Autism Science Foundation sums this concept up nicely: “To be considered evidence-based,
a treatment must be thoroughly investigated in multiple well-designed scientific studies and show
measurable, sustained improvements in targeted areas. A study’s design largely depends on its
focus and purpose, but there are some characteristics that well-designed studies tend to have.” See
their list and brief explanations of these characteristics, along with an overview of some nonevidence based practices, here:
http://www.autismsciencefoundation.org/what-is-autism/autism-diagnosis/beware-non-evidencebased-treatments
Additionally, you should beware of any so-called interventions that can carry significant risk of
physical harm—there are some purported interventions that are not only ineffective at treating
ASD but have caused documented harm.
What do you mean “dangerous practices?”
Remember that there is no “cure” for ASD, and any treatment that claims to be one should be
immediately questioned. Some of the “too good to be true” practices are medically invasive. Not
only is there no indication that they treat ASD at all, but there have been documented cases of
serious harm. These practices include: chelation therapy, bleach therapy, packing/holding
therapy, and Miracle Mineral Solution. You can find some information on these practices on the
Autism Science Foundation site: http://www.autismsciencefoundation.org/what-is-autism/autismdiagnosis/beware-non-evidence-based-treatments
Here are some tips from the Federal Drug Administration, which has been investigating false
treatment claims:
• Be suspicious of products that claim to treat a wide range of diseases.
• Personal testimonials are no substitute for scientific evidence.
• Few disorders can be treated quickly, so be suspicious of any therapy claimed as a
“quick fix.”
• “Miracle cures” which claim scientific breakthroughs and secret ingredients may be a
hoax.
(From here: http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM394800.pdf )
How do I know what the best treatments for autism are?
It is helpful to think about treatments based on the strength of scientific support that they reliably
are helpful for most individuals they are designed to treat. The National Autism Center embarked
on the National Standards Project to evaluate the evidence for different ASD treatments,
specifically to make this information easy for families, caregivers, and practitioners to access
quickly when making treatment choices. They use the following categories:

113






Established Interventions: Have the most research support including multiple wellconducted research studies. Examples: behavioral interventions, parent training,
schedules, social skills packages
Emerging Interventions: Have some evidence but not as much evidence as Established
Treatments. Before we can be assured these interventions are consistently effective,
additional high quality studies are needed. Based on the available evidence, we are not
able to rule out the possibility that these interventions are not effective. We need more
research for a definitive answer. Examples: functional communication training, music
therapy, picture exchange communication system, structured teaching
Unestablished Interventions: There is little to no scientific evidence to support the
effectiveness of these interventions. There is no reason to assume these are effective;
furthermore, there is no way to rule out the possibility they are ineffective or even
harmful. Examples: animal assisted therapy, floor time, facilitated communication,
sensory intervention package

For the complete list and more information on the interventions identified by the National
Standards Project in the above categories, please do the following:
 Go to http://www.nationalautismcenter.org/national-standards-project/phase-2/
 Click on “download the free report.”
 Follow the instructions to access a PDF.
 The coverage of individual interventions begins on page 42.
In summary:
Remember that while every individual with ASD is unique, each has the potential to learn new
skills to decrease problematic behavior, increase his/her independence, and enable him/her to
engage in productive, enjoyable interactions with the environment and people in his/her life.
Interventions targeting an individual’s specific needs can be very helpful in reaching these goals,
but some interventions are more likely to be helpful than others. You should carefully consider
the probable benefits and potential costs when deciding which treatments best fit the needs of
your child and family.

Contact Information:
 If you would like to contact the researchers, you may email Lindsey Williams at
lwil175@lsu.edu or Hilary Adams at hadams15@lsu.edu Note: Up until this point, all
information has been unidentifiable and anonymous; if you choose to email us, your
email will in no way be linked to your participation data.
 This research has been reviewed and approved according to Louisiana State University
Institutional Review Board procedures for research involving human subjects. Questions
about subjects' rights or other concerns can be directed to Robert C. Mathews, Chairman,
Institutional Review Board, (225) 578-8692, irb@lsu.edu, or via www.lsu.edu/irb.
Disclosure statement: The researchers have no ties with the National Autism Center, May
Institute, or Autism Science Foundation. We simply provided the above links and related
information because we think they contain useful information for making informed choices about
ASD interventions.
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APPENDIX B: LOUISIANA STATE UNIVERSITY IRB APPROVAL
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APPENDIX C: NUMBER OF PARTICIPANTS BY RESEARCH QUESTION
Various analyses had different numbers of participants due to reasons such as survey dropout and
not yet having received treatment services. Additionally, the ASD-DC measure included in the
study was developed for use with children ages 2-16; 20 participants fell outside of that age
range and accordingly some analyses were run both with and without these participants when
autism symptom severity was used as a dependent variable in the analysis. This guide is to
outline how many participants were included in each set of analyses and for each individual
analysis, as well as to outline reasons for exclusion at each stage. Research questions are
italicized for easy reference.















Participants in Initial Analyses
Started survey: 150
Retained for initial descriptive analyses: 88
Participants in Analyses on Barriers to Diagnosis
Predictors of greatest number of diagnostic barriers:
o 88 for inclusive analysis
o 68 for analysis excluding those outside of ASD-DC age range
Predictors of professional reassurances as a perceived barrier: 88
Ethnic and familial barriers to diagnostic services: 88
Analyses on Past Treatment
Of the initial 88, 4 participants were removed at this stage because they have not begun
receiving treatment.
Time from diagnosis to treatment
o 84 participants for inclusive analysis
o 63 for analysis excluding those outside ASD-DC age range
For future questions on treatment, 6 more were removed because they dropped out of
survey before answering questions on past treatments, leaving 78 participants for
remaining questions on treatment services.
Factors predicting barriers to EBPs:
o 78 for inclusive analysis
o 60 excluding those outside of age range for ASD-DC
Predictors of time between ASD diagnosis and first ASD symptom treatment:
o 84 for inclusive analysis (4 excluded because had not begun receiving treatment
yet)
o 63 excluding those outside of ASD-DC range
Analyses on Currently Desired Interventions
51 total participants indicated they were interested in future services; of these, 41 of the
answers could be clearly categorized into EBP or non-EBP.
Descriptive analysis: 51
Predictors of desiring EBP over non-EBP: 41
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